{"gene":"RCAN1","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":2000,"finding":"RCAN1 (DSCR1) protein physically interacts with and inhibits calcineurin A (the catalytic subunit of PP2B). The binding region on calcineurin A is located in the linker region between the catalytic domain and the calcineurin B binding domain. Overexpression of RCAN1 inhibits calcineurin-dependent NFAT nuclear translocation and transcriptional activation.","method":"Co-immunoprecipitation, calcineurin phosphatase activity assay, NFAT nuclear translocation assay, overexpression in cell lines","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal binding demonstrated, enzymatic inhibition assay, multiple orthogonal methods, replicated across multiple subsequent studies","pmids":["10861295"],"is_preprint":false},{"year":2006,"finding":"DSCR1 and DYRK1A act synergistically to prevent nuclear occupancy of NFATc transcription factors. Trisomy of both genes cooperatively destabilizes the calcineurin-NFAT regulatory circuit, leading to reduced NFATc activity. Mathematical modeling predicted that autoregulation within the pathway accentuates trisomy effects. Validated in calcineurin- and Nfatc-deficient mice, Dscr1- and Dyrk1a-overexpressing mice, and Down syndrome mouse models.","method":"Mathematical modeling, transgenic mouse models (Dscr1- and Dyrk1a-overexpressing), calcineurin/Nfatc knockout mice, Down syndrome mouse model analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal in vivo genetic models, quantitative modeling validated experimentally, replicated across labs","pmids":["16554754"],"is_preprint":false},{"year":2005,"finding":"A small peptide fragment of DSCR1 competitively inhibits calcineurin phosphatase activity in vitro and in vivo, blocking calcineurin-mediated NFAT nuclear localization.","method":"In vitro calcineurin phosphatase activity assay, in vivo NFAT nuclear localization assay, peptide fragment analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with defined peptide, in vivo validation, single lab but multiple orthogonal methods","pmids":["16131541"],"is_preprint":false},{"year":2009,"finding":"RCAN1 interacts directly with TAB2, recruiting a macromolecular complex containing TAK1, TAB1, and calcineurin. TAK1 phosphorylates RCAN1 at Ser94 and Ser136, converting RCAN1 from an inhibitor to a facilitator of calcineurin-NFAT signaling. This enhances NFATc1 nuclear translocation and hypertrophic cardiomyocyte growth. Calcineurin activation conversely dephosphorylates and inhibits TAK1 and TAB1.","method":"Yeast two-hybrid screen, in vitro binding assay, Co-immunoprecipitation, in vitro phosphorylation assay, site-directed mutagenesis, Rcan1/2- and Tab2-deficient MEF cultures, calcineurin activity assay, NFAT transcriptional reporter","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — yeast two-hybrid, in vitro pulldown, reciprocal Co-IP, in vitro kinase assay with mutagenesis, KO cell validation, multiple orthogonal methods in single rigorous study","pmids":["19136967"],"is_preprint":false},{"year":2011,"finding":"Dyrk1A directly interacts with and phosphorylates RCAN1 at Ser112 and Thr192. Phosphorylation at Ser112 primes RCAN1 for GSK3β-mediated phosphorylation at Ser108. Phosphorylation at Thr192 enhances RCAN1 binding to calcineurin, increasing calcineurin inhibition, reducing NFAT transcriptional activity, and enhancing tau phosphorylation. Dyrk1A-mediated phosphorylation also extends RCAN1 half-life.","method":"In vitro kinase assay, site-directed mutagenesis, Co-immunoprecipitation, calcineurin phosphatase activity assay, NFAT reporter assay, Western blot of Dyrk1A transgenic mouse brain","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with mutagenesis, multiple phosphorylation sites mapped, functional validation via calcineurin activity and NFAT reporter, in vivo validation in transgenic mice","pmids":["21965663"],"is_preprint":false},{"year":2002,"finding":"RCAN1 isoform 1 (calcipressin 1) protects against acute oxidative stress and calcium-mediated stress through calcineurin inhibition. Protection increased as a function of RCAN1 expression and decreased when expression was reduced via antisense oligonucleotides.","method":"Stable RCAN1 transfection in HA-1 cells, tet-off regulated RCAN1 transgene in PC-12 cells, antisense oligonucleotides, H2O2 and calcium ionophore challenge, cross-adaptation assay","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple independent experimental systems (stable transfection, inducible transgene, antisense knockdown), dose-dependent relationship established","pmids":["12039863"],"is_preprint":false},{"year":2009,"finding":"DSCR1/RCAN1 overexpression suppresses tumor angiogenesis through inhibition of the calcineurin pathway in vascular endothelium, sufficient to suppress tumor growth in mice. Targeted deletion of both DSCR1 isoforms leads to hyperactivated calcineurin, precocious endothelial apoptosis, impaired tumor vasculature, and suppressed tumorigenesis. Calcineurin inhibition with cyclosporin A rescues this endothelial defect in DSCR1−/− mice.","method":"Transgenic Dscr1 mouse (single extra copy), DSCR1−/− knockout mice, tumor implantation models, cyclosporin A pharmacological rescue, VEGF-mediated calcineurin-NFAT pathway assays","journal":"Nature / Cancer cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic gain and loss of function in vivo, pharmacological rescue, replicated across two independent Nature/Cancer Cell publications","pmids":["19458618","18455125"],"is_preprint":false},{"year":2004,"finding":"DSCR1/RCAN1 expression in endothelial cells blocks dephosphorylation, nuclear translocation, and transcriptional activity of NFAT (downstream of calcineurin). DSCR1 is most significantly induced by VEGF in a genome-wide analysis. Knockdown of endogenous DSCR1 increases NFAT activity and stimulates inflammatory gene expression (tissue factor, E-selectin, Cox-2).","method":"Genome-wide gene expression analysis, DSCR1 overexpression in endothelial cells, NFAT nuclear translocation assay, siRNA knockdown of DSCR1, inflammatory marker gene expression","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genome-wide screen combined with overexpression and siRNA knockdown, NFAT functional readout, multiple orthogonal methods","pmids":["15016650"],"is_preprint":false},{"year":2007,"finding":"RCAN1 knockout mice exhibit increased calcineurin enzymatic activity, increased abundance of a cleaved calcineurin fragment, decreased phosphorylation of DARPP-32 (a calcineurin substrate), and deficits in spatial learning, associative memory, and late-phase LTP—phenotypes consistent with excess calcineurin signaling.","method":"RCAN1 knockout mouse, calcineurin activity assay, DARPP-32 phosphorylation western blot, behavioral testing (Morris water maze, fear conditioning), electrophysiology (L-LTP)","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean KO with defined molecular (calcineurin activity, substrate phosphorylation) and cellular phenotypes (LTP, behavior), multiple orthogonal readouts","pmids":["18045910"],"is_preprint":false},{"year":2009,"finding":"RCAN1 protein is degraded by both the ubiquitin-proteasome pathway and chaperone-mediated autophagy (CMA) through a CMA-lysosome pathway. Two CMA recognition motifs were identified in RCAN1. Inhibition of CMA increased RCAN1 expression. Inhibition of RCAN1 degradation reduced calcineurin-NFAT activity.","method":"Lysosomal inhibitors, macroautophagy inhibition, CMA disruption, promoter assay for calcineurin-NFAT activity, identification of CMA recognition motifs","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple degradation pathway inhibitors, CMA motif identification, functional consequence on calcineurin-NFAT, single lab","pmids":["19509306"],"is_preprint":false},{"year":2008,"finding":"RCAN1 is a novel ATF6-inducible gene. Activated ATF6 induces the RCAN1 promoter, upregulates RCAN1 mRNA, inhibits calcineurin phosphatase activity, and exerts a growth-modulating effect in cardiac myocytes that is blocked by RCAN1-targeted siRNA.","method":"Transgenic ATF6 mouse model, transcript profiling, adenoviral ATF6 overexpression in cardiac myocytes, RCAN1 promoter-luciferase assay, calcineurin activity assay, siRNA knockdown","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo transgenic model, cell culture mechanistic follow-up with siRNA rescue, calcineurin activity readout, multiple orthogonal methods","pmids":["18319259"],"is_preprint":false},{"year":2006,"finding":"RCAN1 overexpression (via tet-off RCAN1 transgene) inhibits calcineurin (PP2B), leading to increased tau phosphorylation by GSK3β and significantly inhibiting tau degradation by the proteasome in PC12 cells.","method":"Tet-off RCAN1 transgene in PC12 cells, in vitro 20S proteasome degradation assay with recombinant tau, GSK3β phosphorylation assay, okadaic acid and cyclosporin A pharmacological comparisons","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution of tau degradation by purified 20S proteasome, inducible transgene system, pharmacological controls, multiple orthogonal approaches","pmids":["16939415"],"is_preprint":false},{"year":2006,"finding":"Regulated overexpression of an RCAN1 transgene stimulates expression of GSK3β kinase at a post-transcriptional level. RCAN1-1S isoform levels specifically correlate with GSK3β levels in human brain. This positions RCAN1 as a regulator of both calcineurin and the opposing kinase GSK3β.","method":"Regulated RCAN1 transgene expression, Western blotting for GSK3β protein, mRNA analysis (post-transcriptional mechanism), human brain tissue analysis","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — inducible transgene, mRNA vs protein comparison establishing post-transcriptional mechanism, correlation in human tissue, single lab","pmids":["16649988"],"is_preprint":false},{"year":2011,"finding":"Amyloid-β upregulates RCAN1 expression in cortical neurons via Aβ-induced oxidative stress. Increased RCAN1 both inhibits calcineurin (reducing tau dephosphorylation) and upregulates GSK3β (increasing tau phosphorylation), together causing tau hyperphosphorylation. Silencing RCAN1 or adding antioxidants prevented Aβ-induced tau hyperphosphorylation.","method":"Primary fetal rat cortical neuron culture with Aβ treatment, RCAN1 siRNA knockdown, antioxidant treatment, tau phosphorylation western blot, calcineurin activity assay, GSK3β expression analysis","journal":"Journal of Alzheimer's disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA rescue of molecular phenotype, multiple readouts, single lab, in vitro only","pmids":["21876249"],"is_preprint":false},{"year":2011,"finding":"RCAN1-1 overexpression in primary neurons activates caspase-9 and caspase-3, inducing neuronal apoptosis. A functional glucocorticoid response element was identified in the RCAN1 isoform 1 promoter mediating stress-induced upregulation. Neurotoxicity of RCAN1-1 is blocked in caspase-3−/− neurons.","method":"Overexpression in primary neurons, caspase-3/9 activation assay, caspase-3 knockout neurons, glucocorticoid response element identification in RCAN1-1 promoter, dexamethasone treatment","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic rescue (caspase-3 KO), promoter functional analysis, apoptosis mechanistic pathway established, single lab","pmids":["21216952"],"is_preprint":false},{"year":2008,"finding":"RCAN1 regulates vesicle exocytosis in chromaffin cells: Rcan1 loss or overexpression both reduced the number of vesicles undergoing exocytosis. Increasing Rcan1 expression reduced catecholamine released per vesicle and altered fusion pore kinetics. Acute calcineurin inhibition did not replicate the effect of RCAN1 overexpression, indicating a calcineurin-independent mechanism for fusion pore regulation.","method":"RCAN1 overexpressing and knockout mouse chromaffin cells, carbon fibre amperometry, Ca2+ entry measurements, readily releasable pool size assay, acute calcineurin inhibitor comparison","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic gain and loss of function, quantitative single-vesicle amperometry, negative result (calcineurin inhibition does not mimic) mechanistically informative, single lab","pmids":["18180251"],"is_preprint":false},{"year":2012,"finding":"RCAN1-1L induction causes dramatic degradation of mitochondria (mitophagy) involving the adenine nucleotide translocator and mitochondrial permeability transition pore opening, and shifts cellular bioenergetics from aerobic respiration to glycolysis.","method":"Inducible RCAN1-1L expression in neuronal cells, mitochondrial mass/morphology analysis, ANT and mPTP involvement assays, cellular bioenergetics measurement (oxygen consumption vs glycolysis)","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — inducible transgene system, mechanistic dissection of ANT/mPTP pathway, bioenergetics assays, single lab","pmids":["22389495"],"is_preprint":false},{"year":2015,"finding":"RCAN1 (triplicated in Down syndrome) inhibits TrkA receptor endocytosis downstream of calcineurin phosphatase, impairing NGF-dependent neurotrophin trafficking, neuronal survival, and sympathetic innervation. Genetically correcting RCAN1 levels in Down syndrome mice restored NGF-dependent receptor trafficking and neuronal survival.","method":"Down syndrome mouse model, RCAN1 genetic correction, TrkA receptor internalization assay, retrograde NGF trafficking assay, sympathetic innervation quantification, neuronal survival assay","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic rescue experiment in DS mouse model, receptor trafficking directly measured, multiple in vivo readouts, mechanistically placed in calcineurin pathway","pmids":["26658127"],"is_preprint":false},{"year":2018,"finding":"RCAN1 maintains a more fused mitochondrial network by inhibiting calcineurin-dependent activation of the fission protein DRP1. When RCAN1 is depleted, calcineurin activates DRP1, leading to mitochondrial fragmentation, reduced membrane potential, reduced O2 consumption, and impaired mitochondrial Ca2+ buffering. Pharmacological inhibition of calcineurin, DRP1, or calpains (CAPN) restored protection in RCAN1-depleted cardiomyocytes.","method":"RCAN1 KO cardiomyocytes, adenoviral RCAN1 overexpression, DRP1 phosphorylation assay, mitochondrial morphology imaging, pharmacological inhibitors (calcineurin, DRP1, calpain), Down syndrome iPSC disomic/trisomic comparison","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO and gain of function, pharmacological rescue with pathway-specific inhibitors, human DS iPSC validation, multiple orthogonal methods","pmids":["29362227"],"is_preprint":false},{"year":2012,"finding":"RCAN1 (DSCR1) interacts with FMRP and regulates dendritic spine morphogenesis and local protein synthesis. Decreasing FMRP levels restores DSCR1-induced changes in dendritic spine morphology.","method":"Co-immunoprecipitation of DSCR1 and FMRP, dendritic spine morphology analysis, local protein synthesis assay, FMRP knockdown rescue experiment","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, genetic rescue (FMRP knockdown), spine morphology and local synthesis phenotypes, single lab","pmids":["22863780"],"is_preprint":false},{"year":2016,"finding":"RCAN1 (DSCR1) controls axon outgrowth by modulating growth cone actin dynamics through regulation of cofilin phosphorylation/dephosphorylation. RCAN1 also mediates BDNF-induced local protein synthesis and growth cone turning.","method":"DSCR1 loss-of-function in neurons, phospho-cofilin/cofilin ratio measurement, live-imaging of axon outgrowth, BDNF-induced growth cone turning assay, local protein synthesis assay","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with defined molecular readout (cofilin phosphorylation), axon growth and turning assays, single lab","pmids":["27185837"],"is_preprint":false},{"year":2019,"finding":"RCAN1 binds to TET1 introns and regulates TET1 splicing, thereby modulating TET1 protein levels. TET1 controls demethylation of the miR-124 promoter to regulate miR-124 expression, which in turn controls adult hippocampal neurogenesis. Correcting TET1 levels in RCAN1 KO mice prevents defective adult neurogenesis.","method":"RCAN1 KO mice, RNA-binding/splicing assay (RCAN1-TET1 interaction), miR-124 promoter methylation analysis, adult neurogenesis quantification, genetic rescue (TET1 correction in RCAN1 KO), Down syndrome mouse model rescue","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse with defined molecular pathway (TET1 splicing → miR-124 → neurogenesis), genetic rescue, novel non-calcineurin mechanism, single lab","pmids":["31304631"],"is_preprint":false},{"year":2011,"finding":"RCAN1 GSK3β nuclear export switches RCAN1 from a calcineurin inhibitor to a facilitator of calcineurin-NFAT signaling in a dose-dependent manner. PI3K signaling promotes GSK3β nuclear export, enabling the facilitatory role. Sequential phosphorylation of RCAN1 mediates this switch.","method":"Single-cell experimentation, mathematical modeling, PI3K inhibitor treatment, GSK3β nuclear export assay, NFAT reporter assay, dose-response analysis","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — computational modeling validated by single-cell experiments and pharmacological perturbation, dose-dependent mechanistic switch identified, single lab","pmids":["21172821"],"is_preprint":false},{"year":2005,"finding":"Raf-1 is a direct binding partner of DSCR1. Two Raf-1 binding regions were identified in DSCR1 (N-terminus and C-terminus). Calpain cleaves DSCR1 and generates fragments with differential binding affinity to Raf-1 versus calcineurin.","method":"Pulldown assay with DSCR1 as bait, co-immunoprecipitation in GFP-DSCR1 expressing cells, deletion mapping of binding regions, calpain cleavage assay","journal":"Archives of biochemistry and biophysics","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — pulldown and Co-IP, domain mapping, calpain cleavage experiment, single lab, no functional consequence of Raf-1 binding established","pmids":["15935327"],"is_preprint":false},{"year":2012,"finding":"RCAN1-1L promotes CREB phosphorylation and cAMP response element-mediated gene transcription. This effect is dependent on RCAN1's ability to inhibit calcineurin. RCAN1 induces Bcl-2 expression via CREB activation, protecting neurons from H2O2-induced apoptosis. RCAN1 inhibits H2O2-induced MAPK and AP-1 activation.","method":"RCAN1 overexpression and shRNA knockdown in neuronal cells, CREB phosphorylation western blot, CRE-luciferase reporter assay, Bcl-2 expression analysis, H2O2 cytotoxicity assay, calcineurin inhibitor comparison","journal":"The Journal of biological chemistry / Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain and loss of function, calcineurin-dependence established, CREB/Bcl-2 pathway mechanistically linked, single lab","pmids":["21890628","23150431"],"is_preprint":false},{"year":2008,"finding":"CREB activates proteasomal degradation of RCAN1 via the ubiquitin-proteasome pathway. CREB-enhanced ubiquitination of RCAN1 increases its turnover rate. This regulatory function depends on CREB's transcriptional activation.","method":"Proteasome inhibitor treatment, ubiquitination assay, RCAN1 protein turnover (pulse-chase), CREB overexpression and transcriptional activation mutants","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — proteasome inhibitors, ubiquitination assay, transcriptional activation mutant, single lab","pmids":["18485898"],"is_preprint":false},{"year":2008,"finding":"Oxidative stress (H2O2) induces ubiquitination of RCAN1 mediated by SCFβ-TrCP ubiquitin ligase. β-TrCP interacts with RCAN1 in an H2O2-dependent manner. In vitro ubiquitination assay showed SCFβ-TrCP (but not SCFFBW4) ubiquitinates RCAN1 in response to H2O2. Knockdown of β-TrCP abolished H2O2-induced RCAN1 decrease in cells and primary neurons.","method":"Co-immunoprecipitation of β-TrCP and FBW4 with RCAN1, in vitro ubiquitination assay, siRNA knockdown of β-TrCP, primary hippocampal and cortical neuron experiments","journal":"International journal of molecular medicine","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro ubiquitination reconstitution, Co-IP, siRNA rescue, validated in primary neurons, single lab","pmids":["18575781"],"is_preprint":false},{"year":2012,"finding":"NEDD8 is covalently conjugated to RCAN1-1S at lysine residues K96, K104, and K107. Neddylation enhances RCAN1 protein stability by inhibiting proteasomal degradation, increases RCAN1 binding to calcineurin, and potentiates its inhibitory activity toward downstream NFAT signaling.","method":"NEDD8 conjugation mapping to K96/K104/K107 by mutagenesis, protein stability assay, Co-immunoprecipitation of neddylated RCAN1 with calcineurin, NFAT reporter assay, proteasome inhibitor comparison","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — PTM site mapping by mutagenesis, stability assay, binding and functional assay, single lab","pmids":["23118980"],"is_preprint":false},{"year":2003,"finding":"Oxidative stress (H2O2, peroxynitrite, menadione) induces hyperphosphorylation of DSCR1/RCAN1 protein. Phosphorylation of serines in a 13-amino acid calcineurin-interacting conserved region of DSCR1 attenuates its inhibition of calcineurin.","method":"H2O2 and oxidant treatment of human cells, gel mobility shift analysis, kinase inhibitor panel, phosphopeptide synthesis and calcineurin inhibition assay","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro calcineurin assay with phosphopeptides, multiple oxidants tested, single lab","pmids":["12927602"],"is_preprint":false},{"year":2002,"finding":"DSCR1/RCAN1 protein localizes preferentially to the nucleus, independently of isoform, cell line, or GFP orientation. A C-terminal segment is important for nuclear localization. Site-directed mutagenesis indicates serine and threonine residues contribute to nuclear targeting, suggesting phosphorylation regulates localization.","method":"GFP fusion protein imaging in multiple cell lines, deletion mutagenesis, site-directed mutagenesis of serine/threonine residues","journal":"BMC cell biology","confidence":"Low","confidence_rationale":"Tier 3 / Moderate — GFP localization assay with deletion and point mutagenesis, multiple cell lines, but no direct functional consequence of localization demonstrated","pmids":["12225619"],"is_preprint":false},{"year":2011,"finding":"In Drosophila, the RCAN1 ortholog sarah (sra) is required for normal sleep. Sleep reduction in sra mutants correlates with decreased Sra protein levels. Pan-neural sra expression rescues the sleep phenotype. Calcineurin (CanA-14F and CanB subunits) loss also reduces sleep, and sra sleep defects are suppressed by calcineurin mutations, establishing that sra and calcineurin affect sleep through a common mechanism.","method":"Drosophila sra mutants, calcineurin subunit knockout mutants, pan-neural transgenic rescue, constitutively active calcineurin expression, epistasis analysis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — Drosophila ortholog (RCAN family), genetic epistasis establishing common pathway, multiple calcineurin subunit knockouts, transgenic rescue, clean behavioral phenotype with molecular pathway assignment","pmids":["21900555"],"is_preprint":false},{"year":2013,"finding":"Increased dosage of DSCR1 and DYRK1A in neocortical progenitor cells cooperatively suppresses NFATc activity, delaying neuronal differentiation and altering laminar fate in the developing neocortex. Counteracting the dysregulated pathway ameliorates delayed neuronal differentiation in the Ts1Cje Down syndrome mouse model.","method":"In utero electroporation for DYRK1A and DSCR1 overexpression in neocortex, Ts1Cje DS mouse model, NFATc activity assay, neuronal differentiation and laminar fate analysis, pathway rescue","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo neural progenitor experiments with pathway rescue, DS mouse model validation, NFATc mechanistic link established, multiple orthogonal approaches","pmids":["24352425"],"is_preprint":false},{"year":2016,"finding":"RCAN1 overexpression in β-cells causes mitochondrial dysfunction including hyperpolarized membrane potential, reduced oxidative phosphorylation, and low ATP production. This impairs both glucose-stimulated membrane depolarization and ATP-dependent insulin granule exocytosis, causing hypoinsulinemia.","method":"RCAN1-overexpressing mice, in vivo glucose-stimulated insulin secretion test, β-cell mitochondrial membrane potential measurement, oxidative phosphorylation assay, ATP production measurement, insulin granule exocytosis assay","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic mouse model with multiple mechanistic readouts, direct measurement of mitochondrial parameters, single lab","pmids":["27195491"],"is_preprint":false},{"year":2010,"finding":"VEGF induces RCAN1.4 expression in endothelial cells via Ca2+/calcineurin and protein kinase C-delta (PKC-δ) pathways. siRNA knockdown of RCAN1.4 results in decreased cell migration and disrupted tubular morphogenesis. RCAN1.4 knockdown increases NFAT-regulated gene expression, confirming a negative feedback role on calcineurin-NFAT signaling.","method":"PKC and calcineurin inhibitors, siRNA silencing of PKC-δ and RCAN1.4, RCAN1.4 promoter assay, NFAT target gene expression, endothelial cell migration assay, collagen gel tubulogenesis assay","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown, pathway inhibitors, functional cellular assays (migration, tubulogenesis), NFAT reporter, single lab","pmids":["20625401"],"is_preprint":false},{"year":2017,"finding":"RCAN1.4 regulates VEGFR-2 internalization (agonist-stimulated receptor endocytosis) and establishment of endothelial cell polarity in response to VEGF. RCAN1.4 is required for efficient VEGF-mediated cytoskeletal reorganization, directed cell migration, and sprouting angiogenesis. Morpholino silencing of zebrafish RCAN1.4 orthologue disrupted vascular development in vivo.","method":"siRNA-mediated knockdown, adenoviral RCAN1.4 overexpression, VEGFR-2 internalization assay, cell polarity assay, cytoskeletal imaging, directed cell migration, sprouting assay, zebrafish morpholino knockdown","journal":"Angiogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA and overexpression in human cells, in vivo zebrafish validation, VEGFR-2 internalization directly measured, single lab","pmids":["28271280"],"is_preprint":false},{"year":2009,"finding":"RCAN1 (Rcan1) negatively regulates FcεRI-mediated mast cell activation. Rcan1-deficient mast cells show increased calcineurin activity, increased NFAT and NF-κB activation, and increased cytokine production and degranulation. Egr1 transcription factor controls Rcan1 expression through a functional Egr1 binding site in the RCAN1 promoter. Forced expression of Rcan1 in Rcan1-deficient mast cells reduced cytokine production.","method":"Rcan1 KO mast cells, calcineurin activity assay, NFAT and NF-κB reporter assays, cytokine ELISA, passive cutaneous anaphylaxis in vivo, Egr1 promoter analysis, ChIP, Rcan1 reconstitution in KO cells","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Moderate — KO with reconstitution, calcineurin activity directly measured, multiple signaling readouts, in vivo anaphylaxis model, promoter mechanism identified","pmids":["19124655"],"is_preprint":false},{"year":2013,"finding":"RCAN1 deficiency reduces atherosclerosis severity in Apoe−/− mice. Rcan1 regulates CD36 expression in macrophages, and its inactivation reduces oxLDL uptake, resistance to oxLDL-mediated inhibition of macrophage migration, and increases anti-inflammatory markers. Bone marrow transplantation of Apoe−/−Rcan1−/− cells into Apoe−/− recipients confers atherosclerosis resistance, demonstrating the effect is hematopoietic cell-autonomous.","method":"Apoe−/−Rcan1−/− double-knockout mice, bone marrow transplantation, CD36 expression assay, oxLDL uptake assay, macrophage migration assay, atherosclerosis lesion quantification","journal":"EMBO molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO in disease model, bone marrow transplantation for cell autonomy, CD36 and oxLDL uptake mechanistically linked, single lab","pmids":["24127415"],"is_preprint":false},{"year":2015,"finding":"RCAN1 overexpression promotes DRP1-mediated mitochondrial fission and age-dependent tau pathology. Brain-specific overexpression of human RCAN1.1S induces memory and synaptic plasticity deficits, tau pathology, and dysregulation of DRP1 activity associated with mitochondrial dysfunction and oxidative stress.","method":"Brain-specific RCAN1.1S transgenic mice, DRP1 activity assay, mitochondrial morphology analysis, behavioral testing, synaptic plasticity electrophysiology, tau pathology immunostaining","journal":"Acta neuropathologica","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic mouse model with molecular readout (DRP1 activity, tau phosphorylation), behavioral and electrophysiology phenotypes, mechanistic pathway proposed, single lab","pmids":["26497675"],"is_preprint":false},{"year":2023,"finding":"RCAN1 knockdown rescues Huntington's disease patient-derived striatal neurons (MSNs) from degeneration by enhancing calcineurin activity, leading to TFEB nuclear localization through dephosphorylation and activation of autophagy/longevity gene chromatin accessibility. A glibenclamide analog (G2-115) reduces RCAN1-calcineurin interaction, phenocopying RCAN1 knockdown.","method":"Direct neuronal reprogramming of human fibroblasts to MSNs, longitudinal transcriptomics, RCAN1 knockdown (siRNA/shRNA), calcineurin activity assay, TFEB nuclear localization assay, chromatin accessibility (ATAC-seq), pharmacological G2-115 treatment","journal":"Nature aging","confidence":"High","confidence_rationale":"Tier 2 / Moderate — human patient-derived neurons, siRNA rescue, TFEB dephosphorylation and nuclear translocation directly measured, pharmacological mimicry, multiple orthogonal methods, rigorous study","pmids":["38066314"],"is_preprint":false},{"year":2017,"finding":"LRRK2 kinase phosphorylates RCAN1-1S and is upregulated during IL-1β treatment. LRRK2-mediated phosphorylation of RCAN1 promotes formation of Tollip-RCAN1 protein complexes, decreases Tollip-IRAK1 interaction, increases IRAK1-TRAF6 complex formation, enhances TAK1 activity, and promotes NF-κB transcriptional activity and IL-8 production.","method":"In vitro kinase assay, co-immunoprecipitation, NF-κB reporter assay, IL-8 ELISA, LRRK2 and RCAN1 overexpression/knockdown","journal":"Frontiers in cellular neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro kinase assay, Co-IP, NF-κB functional reporter, cytokine readout, single lab","pmids":["28553204"],"is_preprint":false},{"year":2010,"finding":"C/EBPβ directly binds to multiple conserved sites in the RCAN1-4 promoter and cooperates with NFAT to regulate RCAN1-4 expression. A direct protein-protein interaction between C/EBPβ and NFAT was demonstrated, and complex formation occurs at NFAT-C/EBPβ composite sites. Depletion of C/EBPβ decreased maximal RCAN1-4 activation by calcineurin. C/EBPβ occupancy of Rcan1-4 promoter increased in mouse models of heart failure.","method":"EMSA (electrophoretic mobility shift assay), chromatin immunoprecipitation (ChIP), co-immunoprecipitation of C/EBPβ and NFAT, RCAN1-4 luciferase reporter, C/EBPβ depletion, heart failure mouse model","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA, ChIP, Co-IP, functional reporter, in vivo heart failure validation, single lab","pmids":["20371871"],"is_preprint":false},{"year":2019,"finding":"RCAN1.4 expression is epigenetically suppressed by DNA methylation mediated by DNMT1 and DNMT3b, as shown by ChIP assay. RCAN1.4 overexpression alleviates liver fibrosis by inhibiting CaN/NFAT3 signaling. Knockdown of RCAN1.4 exacerbates TGF-β1-induced liver fibrosis in a CaN/NFAT3-dependent manner.","method":"Bisulfite sequencing PCR, ChIP assay with DNMT1/DNMT3b, 5-azadC demethylation, rAAV8-RCAN1.4 in vivo delivery, CaN/NFAT3 reporter and activity assay, liver fibrosis mouse model","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP identifying specific methyltransferases, in vivo AAV rescue, CaN/NFAT3 mechanistic link, single lab","pmids":["31285763"],"is_preprint":false}],"current_model":"RCAN1 (DSCR1) is an endogenous inhibitor of the Ca2+/calmodulin-dependent phosphatase calcineurin that binds directly to calcineurin's linker region to block its phosphatase activity, thereby preventing NFAT dephosphorylation and nuclear translocation; this inhibitory activity is bidirectionally regulated by phosphorylation (TAK1 at Ser94/Ser136 converts RCAN1 to a calcineurin facilitator; Dyrk1A at Thr192 enhances calcineurin inhibition; GSK3β and oxidative-stress-induced phosphorylation attenuate inhibition), by post-translational modification (neddylation stabilizes and potentiates; SCFβ-TrCP ubiquitination and CREB-driven proteasomal degradation reduce RCAN1 levels; CMA-lysosomal degradation also controls abundance), and by isoform-specific expression driven by alternative promoters (RCAN1-4 induced by calcineurin-NFAT feedback; RCAN1-1 by glucocorticoids and oxidative stress; both regulated by ATF6, C/EBPβ, AP-1, and DNMT-mediated methylation); beyond calcineurin, RCAN1 interacts with FMRP to regulate dendritic spine morphology and local protein synthesis, with TET1 to control epigenetic regulation of adult neurogenesis, with TAB2 to form a TAK1-TAB1-TAB2-calcineurin signaling complex, with Raf-1, and with IκBα to modulate NF-κB; at the organelle level RCAN1 restrains calcineurin-dependent DRP1 activation to maintain mitochondrial fusion, and regulates vesicle fusion pore kinetics and exocytosis in a partially calcineurin-independent manner; collectively, these mechanisms position RCAN1 as a context-dependent regulator of calcineurin-NFAT signaling whose dysregulation contributes to Down syndrome cognitive deficits, Alzheimer's-associated tau hyperphosphorylation, tumor angiogenesis suppression, cardiac hypertrophy, β-cell dysfunction, and neurotrophin trafficking."},"narrative":{"mechanistic_narrative":"RCAN1 (DSCR1) is an endogenous regulator of the Ca2+/calmodulin-dependent phosphatase calcineurin that governs the calcineurin–NFAT signaling axis across cardiovascular, neuronal, immune, and metabolic contexts [PMID:10861295, PMID:19458618, PMID:18455125, PMID:19124655]. It binds calcineurin A directly at the linker region between the catalytic and calcineurin-B-binding domains, and a short peptide spanning its conserved calcineurin-interacting region competitively inhibits phosphatase activity, blocking NFAT dephosphorylation, nuclear translocation, and transcription [PMID:10861295, PMID:16131541]. Loss of RCAN1 elevates calcineurin activity in vivo, producing excess substrate dephosphorylation and phenotypes from defective spatial learning and late-phase LTP to hyperactivated endothelial and mast-cell signaling [PMID:18045910, PMID:19124655, PMID:19458618, PMID:18455125]. Its activity is not fixed but switched by phosphorylation: Dyrk1A phosphorylation at Thr192 strengthens calcineurin binding and inhibition while extending RCAN1 half-life, whereas TAK1 phosphorylation at Ser94/Ser136—following RCAN1 binding to TAB2 and recruitment of a TAK1–TAB1–calcineurin complex—and GSK3β nuclear export convert RCAN1 from inhibitor to facilitator of NFAT signaling; oxidative-stress-induced phosphorylation of its conserved region attenuates inhibition [PMID:19136967, PMID:21965663, PMID:21172821, PMID:12927602]. RCAN1 abundance is set by opposing post-translational controls—neddylation at K96/K104/K107 stabilizes and potentiates it, while SCFβ-TrCP ubiquitination, CREB-driven proteasomal turnover, and chaperone-mediated autophagy degrade it—and by isoform-specific transcription through ATF6, C/EBPβ/NFAT feedback, Egr1, glucocorticoid response elements, and DNMT-mediated methylation [PMID:23118980, PMID:18575781, PMID:18485898, PMID:19509306, PMID:18319259, PMID:20371871, PMID:19124655, PMID:21216952, PMID:31285763]. Functionally, RCAN1 dosage controls tumor and developmental angiogenesis via endothelial calcineurin-NFAT and VEGFR-2 trafficking [PMID:19458618, PMID:18455125, PMID:15016650, PMID:28271280], restrains calcineurin-dependent DRP1 activation to preserve mitochondrial fusion [PMID:29362227], and cooperates with DYRK1A to suppress NFATc during neocortical development, a Down syndrome-relevant circuit [PMID:16554754, PMID:24352425]. Beyond calcineurin, RCAN1 interacts with FMRP to regulate dendritic spine morphology and local protein synthesis, with TET1 to control miR-124-dependent adult neurogenesis, and modulates vesicle fusion-pore kinetics in a partially calcineurin-independent manner [PMID:22863780, PMID:31304631, PMID:18180251]. RCAN1 dysregulation drives calcineurin-dependent disease, including Down syndrome neurotrophin-trafficking and differentiation deficits, Alzheimer's-associated tau hyperphosphorylation through combined calcineurin inhibition and GSK3β upregulation, and Huntington's striatal neurodegeneration where RCAN1 knockdown restores calcineurin-TFEB-autophagy signaling [PMID:26658127, PMID:21876249, PMID:38066314].","teleology":[{"year":2000,"claim":"Established that RCAN1 is a direct calcineurin-binding inhibitor, defining its core molecular activity and the calcineurin-NFAT axis it controls.","evidence":"Co-IP, calcineurin phosphatase assay, and NFAT translocation assay with overexpression in cell lines","pmids":["10861295"],"confidence":"High","gaps":["Binding region mapped to the calcineurin linker but no structural model of the complex","Endogenous regulation not yet addressed by overexpression alone"]},{"year":2002,"claim":"Showed that RCAN1-mediated calcineurin inhibition is cytoprotective, linking abundance to resistance against oxidative and calcium stress.","evidence":"Stable and inducible transgene plus antisense knockdown in HA-1/PC-12 cells under H2O2 and ionophore challenge","pmids":["12039863"],"confidence":"High","gaps":["Protective downstream effectors not defined","Isoform-specific contributions not separated"]},{"year":2005,"claim":"Defined the minimal inhibitory unit, showing a short RCAN1 peptide competitively blocks calcineurin, supporting a defined enzymatic mechanism.","evidence":"In vitro and in vivo phosphatase and NFAT localization assays with peptide fragment","pmids":["16131541","15935327"],"confidence":"High","gaps":["Raf-1 binding (15935327) lacks a defined functional consequence","Competition mode versus the full-length protein not fully resolved"]},{"year":2004,"claim":"Placed RCAN1 in a VEGF-driven endothelial negative-feedback loop, establishing a physiological inducer and an anti-inflammatory role for its calcineurin inhibition.","evidence":"Genome-wide expression, overexpression, and siRNA knockdown in endothelial cells with NFAT and inflammatory gene readouts","pmids":["15016650"],"confidence":"High","gaps":["Promoter elements driving VEGF induction not mapped here","In vivo vascular relevance addressed only later"]},{"year":2006,"claim":"Demonstrated cooperative dosage effects of RCAN1 and DYRK1A on NFATc, providing a quantitative model for how trisomy destabilizes calcineurin-NFAT signaling.","evidence":"Mathematical modeling validated in calcineurin/Nfatc-deficient, overexpressing, and Down syndrome mouse models","pmids":["16554754"],"confidence":"High","gaps":["Direct biochemical interplay of the two gene products not dissected","Tissue-specific thresholds not defined"]},{"year":2006,"claim":"Connected RCAN1 to tau pathology, showing it both inhibits calcineurin and upregulates GSK3β to promote tau phosphorylation and block proteasomal tau degradation.","evidence":"Tet-off RCAN1 transgene in PC12 cells, in vitro 20S proteasome degradation assay, GSK3β analysis, and human brain correlation","pmids":["16939415","16649988"],"confidence":"High","gaps":["Mechanism of post-transcriptional GSK3β upregulation unresolved","In vivo tau consequences not yet tested"]},{"year":2008,"claim":"Identified transcriptional and ubiquitin-proteasome controls of RCAN1 abundance, showing ATF6 induces it and CREB and SCFβ-TrCP target it for degradation.","evidence":"ATF6 transgenic mice and promoter assays; proteasome inhibitor, ubiquitination, pulse-chase, and in vitro SCFβ-TrCP reconstitution","pmids":["18319259","18485898","18575781"],"confidence":"Medium","gaps":["Interplay between competing degradation routes not integrated","Single-lab biochemistry for several degradation findings"]},{"year":2003,"claim":"Showed oxidative stress phosphorylates the conserved calcineurin-interacting region of RCAN1, attenuating inhibition and defining redox-sensitive regulation of activity.","evidence":"Oxidant treatment, gel mobility shift, kinase inhibitor panel, and phosphopeptide calcineurin assays","pmids":["12927602"],"confidence":"Medium","gaps":["Responsible kinase(s) not definitively assigned","Phosphosite stoichiometry in cells unquantified"]},{"year":2007,"claim":"Provided genetic proof that endogenous RCAN1 restrains calcineurin in the brain, linking its loss to substrate hyperdephosphorylation and learning/LTP deficits.","evidence":"RCAN1 KO mice with calcineurin activity, DARPP-32 phosphorylation, behavioral, and electrophysiology assays","pmids":["18045910"],"confidence":"High","gaps":["Cell types responsible for behavioral deficits not isolated","Cleaved calcineurin fragment origin unexplained"]},{"year":2009,"claim":"Revealed the TAK1-driven inhibitor-to-facilitator switch, showing RCAN1–TAB2 recruits a TAK1–TAB1–calcineurin complex and Ser94/Ser136 phosphorylation reverses RCAN1's role.","evidence":"Yeast two-hybrid, in vitro binding and kinase assays, mutagenesis, KO MEFs, and NFAT reporter in cardiomyocyte hypertrophy","pmids":["19136967"],"confidence":"High","gaps":["In vivo cardiac requirement of the switch not established here","Structural basis of the multiprotein complex unknown"]},{"year":2009,"claim":"Extended RCAN1 turnover control to chaperone-mediated autophagy and broadened its immune role as an Egr1-controlled brake on FcεRI-mediated mast cell activation.","evidence":"CMA/lysosome inhibitor and motif analysis; Rcan1 KO mast cells with reconstitution, calcineurin/NFAT/NF-κB readouts, ChIP, and anaphylaxis model","pmids":["19509306","19124655"],"confidence":"Medium","gaps":["Relative flux through CMA versus proteasome in vivo unclear","Direct NF-κB regulation mechanism not fully defined"]},{"year":2011,"claim":"Mapped Dyrk1A and GSK3β phosphorylation as the molecular tuner of RCAN1, with Thr192 enhancing calcineurin inhibition and GSK3β nuclear export enabling the facilitatory state.","evidence":"In vitro kinase assays, mutagenesis, Co-IP, calcineurin/NFAT assays, single-cell modeling, and PI3K inhibition","pmids":["21965663","21172821"],"confidence":"High","gaps":["Quantitative thresholds dictating inhibitor versus facilitator state in vivo unknown","Cross-talk with TAK1-mediated switch not integrated"]},{"year":2011,"claim":"Linked stress-induced RCAN1-1 to neuronal apoptosis and tau pathology, showing a glucocorticoid response element and Aβ/oxidative-stress induction converge on caspase activation and tau hyperphosphorylation.","evidence":"Primary neuron overexpression and siRNA, caspase assays, caspase-3 KO rescue, GRE identification, and Aβ/antioxidant treatments","pmids":["21216952","21876249"],"confidence":"Medium","gaps":["In vivo relevance to Alzheimer's progression not tested","Single-lab in vitro neuronal systems"]},{"year":2012,"claim":"Established neddylation as a stabilizing, potentiating modification and uncovered RCAN1 protein-protein roles beyond calcineurin via FMRP at dendritic spines and CREB-Bcl-2 survival signaling.","evidence":"NEDD8 site mapping and stability/binding assays; FMRP Co-IP with spine and local-synthesis rescue; CREB/Bcl-2 reporter and H2O2 cytotoxicity assays","pmids":["23118980","22863780","21890628","23150431"],"confidence":"Medium","gaps":["NEDD8 conjugating machinery for RCAN1 not identified","FMRP-dependent function not mechanistically separated from calcineurin"]},{"year":2012,"claim":"Connected RCAN1 to mitochondrial and vesicular physiology, showing RCAN1-1L drives mitophagy/bioenergetic shift and that fusion-pore regulation is partly calcineurin-independent.","evidence":"Inducible RCAN1-1L in neuronal cells with ANT/mPTP and bioenergetic assays; chromaffin-cell amperometry in KO/overexpressing mice","pmids":["22389495","18180251"],"confidence":"Medium","gaps":["Calcineurin-independent fusion-pore effector unidentified","Mechanism coupling RCAN1 to ANT/mPTP unresolved"]},{"year":2013,"claim":"Demonstrated developmental and atherosclerotic roles, with RCAN1/DYRK1A suppressing NFATc in neocortical progenitors and RCAN1 regulating macrophage CD36 and oxLDL uptake.","evidence":"In utero electroporation and Ts1Cje rescue; Apoe-/-Rcan1-/- mice with bone marrow transplantation and CD36/oxLDL assays","pmids":["24352425","24127415"],"confidence":"Medium","gaps":["Direct calcineurin dependence of CD36 regulation not established","Neuronal versus vascular dosage effects not unified"]},{"year":2015,"claim":"Showed RCAN1 dosage controls NGF/TrkA neurotrophin trafficking and, when overexpressed, drives DRP1-mediated fission with tau pathology, mechanistically linking it to Down syndrome and tauopathy.","evidence":"Down syndrome mouse genetic correction with TrkA internalization and survival assays; brain-specific RCAN1.1S transgenic mice with DRP1, behavioral, and tau readouts","pmids":["26658127","26497675"],"confidence":"High","gaps":["Mechanism by which RCAN1 controls receptor endocytosis only partly defined","Reconciliation of fission (overexpression) versus fusion (depletion) phenotypes incomplete"]},{"year":2016,"claim":"Extended RCAN1 mitochondrial control to β-cells, showing overexpression impairs oxidative phosphorylation, ATP production, and glucose-stimulated insulin exocytosis.","evidence":"RCAN1-overexpressing mice with in vivo insulin secretion, membrane potential, OXPHOS, ATP, and granule exocytosis assays","pmids":["27195491"],"confidence":"Medium","gaps":["Calcineurin-dependence of the β-cell phenotype not isolated","Single-lab transgenic model"]},{"year":2017,"claim":"Resolved how RCAN1 maintains mitochondrial fusion by restraining calcineurin-dependent DRP1 activation, and broadened its signaling roles to VEGFR-2 trafficking and LRRK2-Tollip-NF-κB inflammation.","evidence":"RCAN1 KO/overexpressing cardiomyocytes with DS iPSC and pharmacological rescue; VEGFR-2 internalization and zebrafish morpholino; LRRK2 kinase, Co-IP, and NF-κB/IL-8 assays","pmids":["29362227","28271280","28553204"],"confidence":"High","gaps":["LRRK2-RCAN1 inflammatory axis (28553204) single-lab and Medium-confidence","Direct DRP1 regulation versus calpain contribution not fully separated"]},{"year":2019,"claim":"Uncovered a calcineurin-independent epigenetic function whereby RCAN1 binds TET1 introns to regulate splicing and miR-124-dependent adult neurogenesis, and showed DNMT methylation silences RCAN1.4 in fibrosis.","evidence":"RCAN1 KO mice with splicing/methylation/neurogenesis assays and TET1 genetic rescue; ChIP/bisulfite analysis with AAV rescue in liver fibrosis","pmids":["31304631","31285763"],"confidence":"Medium","gaps":["Biochemical basis of RCAN1 RNA-binding/splicing activity undefined","Relationship of TET1 role to calcineurin functions unknown"]},{"year":2023,"claim":"Demonstrated therapeutic relevance in neurodegeneration, showing RCAN1 knockdown enhances calcineurin-TFEB-autophagy signaling to rescue Huntington's patient-derived neurons, mimicked pharmacologically.","evidence":"Patient-derived reprogrammed MSNs with RCAN1 knockdown, calcineurin/TFEB and ATAC-seq readouts, and G2-115 disruption of RCAN1-calcineurin","pmids":["38066314"],"confidence":"High","gaps":["In vivo efficacy of RCAN1-calcineurin disruption not established","Specificity of G2-115 for the RCAN1-calcineurin interface not fully characterized"]},{"year":null,"claim":"How RCAN1's calcineurin-dependent and calcineurin-independent activities (RNA/splicing with TET1, FMRP-linked local translation, fusion-pore kinetics) are coordinated, and what structural features encode the inhibitor-versus-facilitator switch, remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of the RCAN1-calcineurin complex or of the phosphorylation-dependent conformational switch","Molecular basis of RCAN1 nucleic-acid binding undefined","Quantitative rules governing dosage-dependent role reversal in vivo unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,2,4,27]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,2]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[21]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[29]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[18,16,32]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,3,7]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,7,40]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[35,7]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[27,26,25,9]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[18,16]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[9,38]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[31,6,34]}],"complexes":["TAK1-TAB1-TAB2-calcineurin signaling complex"],"partners":["PPP3CA","DYRK1A","TAB2","TAK1","FMRP","TET1","RAF1","BTRC"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P53805","full_name":"Calcipressin-1","aliases":["Adapt78","Down syndrome critical region protein 1","Myocyte-enriched calcineurin-interacting protein 1","MCIP1","Regulator of calcineurin 1"],"length_aa":252,"mass_kda":28.1,"function":"Inhibits calcineurin-dependent transcriptional responses by binding to the catalytic domain of calcineurin A (PubMed:12809556). Could play a role during central nervous system development (By similarity)","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/P53805/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RCAN1","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CALM2","stoichiometry":0.2},{"gene":"CALM3","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/RCAN1","total_profiled":1310},"omim":[{"mim_id":"615321","title":"CHLORIDE INTRACELLULAR CHANNEL 6; CLIC6","url":"https://www.omim.org/entry/615321"},{"mim_id":"605860","title":"RCAN FAMILY MEMBER 3; RCAN3","url":"https://www.omim.org/entry/605860"},{"mim_id":"605602","title":"MYOZENIN 2; MYOZ2","url":"https://www.omim.org/entry/605602"},{"mim_id":"602917","title":"REGULATOR OF CALCINEURIN 1; RCAN1","url":"https://www.omim.org/entry/602917"},{"mim_id":"600855","title":"DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 1A; DYRK1A","url":"https://www.omim.org/entry/600855"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"liver","ntpm":239.5},{"tissue":"parathyroid gland","ntpm":426.0}],"url":"https://www.proteinatlas.org/search/RCAN1"},"hgnc":{"alias_symbol":[],"prev_symbol":["DSCR1"]},"alphafold":{"accession":"P53805","domains":[{"cath_id":"3.30.70.330","chopping":"74-135","consensus_level":"high","plddt":95.199,"start":74,"end":135}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P53805","model_url":"https://alphafold.ebi.ac.uk/files/AF-P53805-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P53805-F1-predicted_aligned_error_v6.png","plddt_mean":73.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RCAN1","jax_strain_url":"https://www.jax.org/strain/search?query=RCAN1"},"sequence":{"accession":"P53805","fasta_url":"https://rest.uniprot.org/uniprotkb/P53805.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P53805/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P53805"}},"corpus_meta":[{"pmid":"16554754","id":"PMC_16554754","title":"NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21.","date":"2006","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16554754","citation_count":534,"is_preprint":false},{"pmid":"10861295","id":"PMC_10861295","title":"DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways.","date":"2000","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10861295","citation_count":398,"is_preprint":false},{"pmid":"19458618","id":"PMC_19458618","title":"Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1.","date":"2009","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/19458618","citation_count":286,"is_preprint":false},{"pmid":"11483593","id":"PMC_11483593","title":"Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimer's disease.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11483593","citation_count":177,"is_preprint":false},{"pmid":"9325060","id":"PMC_9325060","title":"Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene.","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9325060","citation_count":165,"is_preprint":false},{"pmid":"16939415","id":"PMC_16939415","title":"Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16939415","citation_count":148,"is_preprint":false},{"pmid":"15016650","id":"PMC_15016650","title":"Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells.","date":"2004","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15016650","citation_count":139,"is_preprint":false},{"pmid":"19136967","id":"PMC_19136967","title":"Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point.","date":"2009","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19136967","citation_count":113,"is_preprint":false},{"pmid":"27872486","id":"PMC_27872486","title":"Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway.","date":"2016","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/27872486","citation_count":112,"is_preprint":false},{"pmid":"12039863","id":"PMC_12039863","title":"The DSCR1 (Adapt78) isoform 1 protein calcipressin 1 inhibits calcineurin and protects against acute calcium-mediated stress damage, including transient oxidative stress.","date":"2002","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/12039863","citation_count":111,"is_preprint":false},{"pmid":"18455125","id":"PMC_18455125","title":"Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth.","date":"2008","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/18455125","citation_count":111,"is_preprint":false},{"pmid":"21876249","id":"PMC_21876249","title":"Amyloid-β toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer's disease.","date":"2011","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/21876249","citation_count":109,"is_preprint":false},{"pmid":"19509306","id":"PMC_19509306","title":"Degradation of regulator of calcineurin 1 (RCAN1) is mediated by both chaperone-mediated autophagy and ubiquitin proteasome pathways.","date":"2009","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/19509306","citation_count":101,"is_preprint":false},{"pmid":"21216952","id":"PMC_21216952","title":"Regulator of calcineurin 1 (RCAN1) facilitates neuronal apoptosis through caspase-3 activation.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21216952","citation_count":97,"is_preprint":false},{"pmid":"16131541","id":"PMC_16131541","title":"Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16131541","citation_count":97,"is_preprint":false},{"pmid":"18045910","id":"PMC_18045910","title":"The Down syndrome critical region protein RCAN1 regulates long-term potentiation and memory via inhibition of phosphatase signaling.","date":"2007","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18045910","citation_count":92,"is_preprint":false},{"pmid":"32004570","id":"PMC_32004570","title":"Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4.","date":"2020","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/32004570","citation_count":91,"is_preprint":false},{"pmid":"16231093","id":"PMC_16231093","title":"Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product calcipressin 1 (or RCAN1) in disease.","date":"2005","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/16231093","citation_count":90,"is_preprint":false},{"pmid":"18319259","id":"PMC_18319259","title":"Coordination of growth and endoplasmic reticulum stress signaling by regulator of calcineurin 1 (RCAN1), a novel ATF6-inducible gene.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18319259","citation_count":87,"is_preprint":false},{"pmid":"17341486","id":"PMC_17341486","title":"RCAN1 (DSCR1) increases neuronal susceptibility to oxidative stress: a potential pathogenic process in neurodegeneration.","date":"2007","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17341486","citation_count":74,"is_preprint":false},{"pmid":"22511596","id":"PMC_22511596","title":"Over-expression of RCAN1 causes Down syndrome-like hippocampal deficits that alter learning and memory.","date":"2012","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22511596","citation_count":70,"is_preprint":false},{"pmid":"18180251","id":"PMC_18180251","title":"DSCR1/RCAN1 regulates vesicle exocytosis and fusion pore kinetics: implications for Down syndrome and Alzheimer's disease.","date":"2008","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18180251","citation_count":69,"is_preprint":false},{"pmid":"21965663","id":"PMC_21965663","title":"Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21965663","citation_count":68,"is_preprint":false},{"pmid":"19192387","id":"PMC_19192387","title":"Two key genes closely implicated with the neuropathological characteristics in Down syndrome: DYRK1A and RCAN1.","date":"2009","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/19192387","citation_count":67,"is_preprint":false},{"pmid":"10756093","id":"PMC_10756093","title":"A new gene family including DSCR1 (Down Syndrome Candidate Region 1) and ZAKI-4: characterization from yeast to human and identification of DSCR1-like 2, a novel human member (DSCR1L2).","date":"2000","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/10756093","citation_count":67,"is_preprint":false},{"pmid":"17331188","id":"PMC_17331188","title":"RCAN1-1L is overexpressed in neurons of Alzheimer's disease patients.","date":"2007","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/17331188","citation_count":66,"is_preprint":false},{"pmid":"12927602","id":"PMC_12927602","title":"Oxidative and calcium stress regulate DSCR1 (Adapt78/MCIP1) protein.","date":"2003","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12927602","citation_count":63,"is_preprint":false},{"pmid":"23038757","id":"PMC_23038757","title":"Regulation of RCAN1 translation and its role in oxidative stress-induced apoptosis.","date":"2012","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/23038757","citation_count":63,"is_preprint":false},{"pmid":"26497675","id":"PMC_26497675","title":"RCAN1 overexpression promotes age-dependent mitochondrial dysregulation related to neurodegeneration in Alzheimer's disease.","date":"2015","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/26497675","citation_count":60,"is_preprint":false},{"pmid":"22389495","id":"PMC_22389495","title":"Chronic expression of RCAN1-1L protein induces mitochondrial autophagy and metabolic shift from oxidative phosphorylation to glycolysis in neuronal cells.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22389495","citation_count":59,"is_preprint":false},{"pmid":"28271280","id":"PMC_28271280","title":"RCAN1.4 regulates VEGFR-2 internalisation, cell polarity and migration in human microvascular endothelial cells.","date":"2017","source":"Angiogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/28271280","citation_count":57,"is_preprint":false},{"pmid":"11231093","id":"PMC_11231093","title":"Dscr1, a novel endogenous inhibitor of calcineurin signaling, is expressed in the primitive ventricle of the heart and during neurogenesis.","date":"2001","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11231093","citation_count":57,"is_preprint":false},{"pmid":"16442855","id":"PMC_16442855","title":"Alzheimer's disease and endocytic dysfunction: clues from the Down syndrome-related proteins, DSCR1 and ITSN1.","date":"2006","source":"Ageing research reviews","url":"https://pubmed.ncbi.nlm.nih.gov/16442855","citation_count":56,"is_preprint":false},{"pmid":"32771023","id":"PMC_32771023","title":"Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma.","date":"2020","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32771023","citation_count":56,"is_preprint":false},{"pmid":"18293408","id":"PMC_18293408","title":"Calcium/calcineurin signaling in primary cortical astrocyte cultures: Rcan1-4 and cyclooxygenase-2 as NFAT target genes.","date":"2008","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/18293408","citation_count":55,"is_preprint":false},{"pmid":"16649988","id":"PMC_16649988","title":"RCAN1 (DSCR1 or Adapt78) stimulates expression of GSK-3beta.","date":"2006","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/16649988","citation_count":53,"is_preprint":false},{"pmid":"22397398","id":"PMC_22397398","title":"Regulator of calcineurin 1 (Rcan1) has a protective role in brain ischemia/reperfusion injury.","date":"2012","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/22397398","citation_count":52,"is_preprint":false},{"pmid":"29362227","id":"PMC_29362227","title":"Down Syndrome Critical Region 1 Gene, Rcan1, Helps Maintain a More Fused Mitochondrial Network.","date":"2018","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/29362227","citation_count":50,"is_preprint":false},{"pmid":"23028325","id":"PMC_23028325","title":"Kaposi's sarcoma herpesvirus K15 protein contributes to virus-induced angiogenesis by recruiting PLCγ1 and activating NFAT1-dependent RCAN1 expression.","date":"2012","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/23028325","citation_count":50,"is_preprint":false},{"pmid":"28289712","id":"PMC_28289712","title":"RCAN1-4 is a thyroid cancer growth and metastasis suppressor.","date":"2017","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/28289712","citation_count":49,"is_preprint":false},{"pmid":"31285763","id":"PMC_31285763","title":"Methylation of RCAN1.4 mediated by DNMT1 and DNMT3b enhances hepatic stellate cell activation and liver fibrogenesis through Calcineurin/NFAT3 signaling.","date":"2019","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/31285763","citation_count":48,"is_preprint":false},{"pmid":"21900555","id":"PMC_21900555","title":"Calcineurin and its regulator sra/DSCR1 are essential for sleep in Drosophila.","date":"2011","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21900555","citation_count":46,"is_preprint":false},{"pmid":"22863780","id":"PMC_22863780","title":"DSCR1 interacts with FMRP and is required for spine morphogenesis and local protein synthesis.","date":"2012","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/22863780","citation_count":45,"is_preprint":false},{"pmid":"24352425","id":"PMC_24352425","title":"Increased dosage of DYRK1A and DSCR1 delays neuronal differentiation in neocortical progenitor cells.","date":"2013","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/24352425","citation_count":43,"is_preprint":false},{"pmid":"27195491","id":"PMC_27195491","title":"A Syntenic Cross Species Aneuploidy Genetic Screen Links RCAN1 Expression to β-Cell Mitochondrial Dysfunction in Type 2 Diabetes.","date":"2016","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27195491","citation_count":43,"is_preprint":false},{"pmid":"26658127","id":"PMC_26658127","title":"RCAN1 links impaired neurotrophin trafficking to aberrant development of the sympathetic nervous system in Down syndrome.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26658127","citation_count":43,"is_preprint":false},{"pmid":"24751678","id":"PMC_24751678","title":"RCAN1 overexpression exacerbates calcium overloading-induced neuronal apoptosis.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24751678","citation_count":41,"is_preprint":false},{"pmid":"23011918","id":"PMC_23011918","title":"Increased expression of the glucose-responsive gene, RCAN1, causes hypoinsulinemia, β-cell dysfunction, and diabetes.","date":"2012","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/23011918","citation_count":41,"is_preprint":false},{"pmid":"21172821","id":"PMC_21172821","title":"A hidden incoherent switch regulates RCAN1 in the calcineurin-NFAT signaling network.","date":"2011","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/21172821","citation_count":41,"is_preprint":false},{"pmid":"24838101","id":"PMC_24838101","title":"Calcineurin and its regulator, RCAN1, confer time-of-day changes in susceptibility of the heart to ischemia/reperfusion.","date":"2014","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/24838101","citation_count":40,"is_preprint":false},{"pmid":"20625401","id":"PMC_20625401","title":"VEGF stimulates RCAN1.4 expression in endothelial cells via a pathway requiring Ca2+/calcineurin and protein kinase C-delta.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20625401","citation_count":40,"is_preprint":false},{"pmid":"15009650","id":"PMC_15009650","title":"Aggregate formation and synaptic abnormality induced by DSCR1.","date":"2004","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15009650","citation_count":40,"is_preprint":false},{"pmid":"21680892","id":"PMC_21680892","title":"Do RCAN1 proteins link chronic stress with neurodegeneration?","date":"2011","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/21680892","citation_count":39,"is_preprint":false},{"pmid":"30139658","id":"PMC_30139658","title":"RCAN1 is a marker of oxidative stress, induced in acute pancreatitis.","date":"2018","source":"Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]","url":"https://pubmed.ncbi.nlm.nih.gov/30139658","citation_count":39,"is_preprint":false},{"pmid":"24127415","id":"PMC_24127415","title":"A major role for RCAN1 in atherosclerosis progression.","date":"2013","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24127415","citation_count":38,"is_preprint":false},{"pmid":"24505143","id":"PMC_24505143","title":"Calcineurin-NFAT activation and DSCR-1 auto-inhibitory loop: how is homoeostasis regulated?","date":"2014","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24505143","citation_count":37,"is_preprint":false},{"pmid":"31880863","id":"PMC_31880863","title":"Genome-wide mRNA profiling identifies RCAN1 and GADD45A as regulators of the transitional switch from survival to apoptosis during ER stress.","date":"2020","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/31880863","citation_count":36,"is_preprint":false},{"pmid":"19270310","id":"PMC_19270310","title":"Regulator of calcineurin (RCAN1-1L) is deficient in Huntington disease and protective against mutant huntingtin toxicity in vitro.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19270310","citation_count":36,"is_preprint":false},{"pmid":"23369757","id":"PMC_23369757","title":"Chronic high levels of the RCAN1-1 protein may promote neurodegeneration and Alzheimer disease.","date":"2013","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23369757","citation_count":35,"is_preprint":false},{"pmid":"21364922","id":"PMC_21364922","title":"Behavioral characterization of a mouse model overexpressing DSCR1/ RCAN1.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21364922","citation_count":34,"is_preprint":false},{"pmid":"24752590","id":"PMC_24752590","title":"Aberrant expression of RCAN1 in Alzheimer's pathogenesis: a new molecular mechanism and a novel drug target.","date":"2014","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/24752590","citation_count":32,"is_preprint":false},{"pmid":"25377251","id":"PMC_25377251","title":"Overexpression of Rcan1-1L inhibits hypoxia-induced cell apoptosis through induction of mitophagy.","date":"2014","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/25377251","citation_count":32,"is_preprint":false},{"pmid":"20371871","id":"PMC_20371871","title":"The CCAAT/enhancer binding protein beta (C/EBPbeta) cooperates with NFAT to control expression of the calcineurin regulatory protein RCAN1-4.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20371871","citation_count":32,"is_preprint":false},{"pmid":"24086147","id":"PMC_24086147","title":"Nebula/DSCR1 upregulation delays neurodegeneration and protects against APP-induced axonal transport defects by restoring calcineurin and GSK-3β signaling.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24086147","citation_count":31,"is_preprint":false},{"pmid":"29094385","id":"PMC_29094385","title":"The neuronal and endocrine roles of RCAN1 in health and disease.","date":"2017","source":"Clinical and experimental pharmacology & physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29094385","citation_count":30,"is_preprint":false},{"pmid":"14718387","id":"PMC_14718387","title":"DSCR1(Adapt78) modulates expression of SOD1.","date":"2004","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/14718387","citation_count":30,"is_preprint":false},{"pmid":"26492364","id":"PMC_26492364","title":"The RCAN1 inhibits NF-κB and suppresses lymphoma growth in mice.","date":"2015","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/26492364","citation_count":29,"is_preprint":false},{"pmid":"19926569","id":"PMC_19926569","title":"Integrative genomics identifies DSCR1 (RCAN1) as a novel NFAT-dependent mediator of phenotypic modulation in vascular smooth muscle cells.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19926569","citation_count":29,"is_preprint":false},{"pmid":"18485347","id":"PMC_18485347","title":"Upregulation of DSCR1 (RCAN1 or Adapt78) in the peri-infarct cortex after experimental stroke.","date":"2008","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/18485347","citation_count":28,"is_preprint":false},{"pmid":"30366682","id":"PMC_30366682","title":"Epigenetic regulation of RCAN1 expression in kidney disease and its role in podocyte injury.","date":"2018","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/30366682","citation_count":28,"is_preprint":false},{"pmid":"18641051","id":"PMC_18641051","title":"c-Jun inhibits thapsigargin-induced ER stress through up-regulation of DSCR1/Adapt78.","date":"2008","source":"Experimental biology and medicine (Maywood, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/18641051","citation_count":27,"is_preprint":false},{"pmid":"32122140","id":"PMC_32122140","title":"Inhibition of miR-103a-3p suppresses the proliferation in oral squamous cell carcinoma cells via targeting RCAN1.","date":"2020","source":"Neoplasma","url":"https://pubmed.ncbi.nlm.nih.gov/32122140","citation_count":26,"is_preprint":false},{"pmid":"15935327","id":"PMC_15935327","title":"Raf-1 is a binding partner of DSCR1.","date":"2005","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/15935327","citation_count":26,"is_preprint":false},{"pmid":"27185837","id":"PMC_27185837","title":"DSCR1 is required for both axonal growth cone extension and steering.","date":"2016","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27185837","citation_count":26,"is_preprint":false},{"pmid":"25009690","id":"PMC_25009690","title":"RCAN1 regulates mitochondrial function and increases susceptibility to oxidative stress in mammalian cells.","date":"2014","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/25009690","citation_count":25,"is_preprint":false},{"pmid":"19124655","id":"PMC_19124655","title":"Rcan1 negatively regulates Fc epsilonRI-mediated signaling and mast cell function.","date":"2009","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19124655","citation_count":24,"is_preprint":false},{"pmid":"11080588","id":"PMC_11080588","title":"The murine DSCR1-like (Down syndrome candidate region 1) gene family: conserved synteny with the human orthologous genes.","date":"2000","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/11080588","citation_count":24,"is_preprint":false},{"pmid":"24051307","id":"PMC_24051307","title":"A single extra copy of Dscr1 improves survival of mice developing spontaneous lung tumors through suppression of tumor angiogenesis.","date":"2013","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/24051307","citation_count":23,"is_preprint":false},{"pmid":"17910944","id":"PMC_17910944","title":"Brain expression of the calcineurin inhibitor RCAN1 (Adapt78).","date":"2007","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/17910944","citation_count":22,"is_preprint":false},{"pmid":"12225619","id":"PMC_12225619","title":"Mutational analyses of the signals involved in the subcellular location of DSCR1.","date":"2002","source":"BMC cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12225619","citation_count":21,"is_preprint":false},{"pmid":"19725972","id":"PMC_19725972","title":"Glucocorticoid evoked upregulation of RCAN1-1 in human leukemic CEM cells susceptible to apoptosis.","date":"2009","source":"Journal of molecular signaling","url":"https://pubmed.ncbi.nlm.nih.gov/19725972","citation_count":21,"is_preprint":false},{"pmid":"39053690","id":"PMC_39053690","title":"Suppression of RCAN1 alleviated lipid accumulation and mitochondrial fission in diabetic cardiomyopathy.","date":"2024","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/39053690","citation_count":20,"is_preprint":false},{"pmid":"18485898","id":"PMC_18485898","title":"CREB activates proteasomal degradation of DSCR1/RCAN1.","date":"2008","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/18485898","citation_count":20,"is_preprint":false},{"pmid":"17596961","id":"PMC_17596961","title":"Overexpression of DSCR1 blocks zinc-induced neuronal cell death through the formation of nuclear aggregates.","date":"2007","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/17596961","citation_count":20,"is_preprint":false},{"pmid":"21890628","id":"PMC_21890628","title":"The regulator of calcineurin 1 (RCAN1/DSCR1) activates the cAMP response element-binding protein (CREB) pathway.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21890628","citation_count":20,"is_preprint":false},{"pmid":"30267660","id":"PMC_30267660","title":"RCAN1.4 acts as a suppressor of cancer progression and sunitinib resistance in clear cell renal cell carcinoma.","date":"2018","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/30267660","citation_count":20,"is_preprint":false},{"pmid":"28553204","id":"PMC_28553204","title":"Leucine-Rich Repeat Kinase 2 (LRRK2) Stimulates IL-1β-Mediated Inflammatory Signaling through Phosphorylation of RCAN1.","date":"2017","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28553204","citation_count":20,"is_preprint":false},{"pmid":"31304631","id":"PMC_31304631","title":"DSCR1-mediated TET1 splicing regulates miR-124 expression to control adult hippocampal neurogenesis.","date":"2019","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/31304631","citation_count":19,"is_preprint":false},{"pmid":"28712932","id":"PMC_28712932","title":"Pyrrolidine dithiocarbamate (PDTC) inhibits inflammatory signaling via expression of regulator of calcineurin activity 1 (RCAN1): Anti-inflammatory mechanism of PDTC through RCAN1 induction.","date":"2017","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28712932","citation_count":19,"is_preprint":false},{"pmid":"22128263","id":"PMC_22128263","title":"Regulator of Calcineurin 1 Isoform 4 (RCAN1.4) Is Overexpressed in the Glomeruli of Diabetic Mice.","date":"2011","source":"The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22128263","citation_count":19,"is_preprint":false},{"pmid":"36305917","id":"PMC_36305917","title":"RCAN1 deficiency aggravates sepsis-induced cardiac remodeling and dysfunction by accelerating mitochondrial pathological fission.","date":"2022","source":"Inflammation research : official journal of the European Histamine Research Society ... [et al.]","url":"https://pubmed.ncbi.nlm.nih.gov/36305917","citation_count":18,"is_preprint":false},{"pmid":"17610901","id":"PMC_17610901","title":"Down syndrome candidate region 1-like 1 (DSCR1-L1) mimics the inhibitory effects of DSCR1 on calcineurin signaling in endothelial cells and inhibits angiogenesis.","date":"2007","source":"The Journal of surgical research","url":"https://pubmed.ncbi.nlm.nih.gov/17610901","citation_count":18,"is_preprint":false},{"pmid":"23118980","id":"PMC_23118980","title":"Covalent NEDD8 conjugation increases RCAN1 protein stability and potentiates its inhibitory action on calcineurin.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23118980","citation_count":18,"is_preprint":false},{"pmid":"12716059","id":"PMC_12716059","title":"DSCR1(Adapt78)--a Janus gene providing stress protection but causing Alzheimer's disease?","date":"2003","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/12716059","citation_count":18,"is_preprint":false},{"pmid":"38066314","id":"PMC_38066314","title":"Longitudinal modeling of human neuronal aging reveals the contribution of the RCAN1-TFEB pathway to Huntington's disease neurodegeneration.","date":"2023","source":"Nature aging","url":"https://pubmed.ncbi.nlm.nih.gov/38066314","citation_count":17,"is_preprint":false},{"pmid":"24218457","id":"PMC_24218457","title":"Calcineurin-Rcan1 interaction contributes to stem cell factor-mediated mast cell activation.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24218457","citation_count":17,"is_preprint":false},{"pmid":"18575781","id":"PMC_18575781","title":"Oxidative stress-induced ubiquitination of RCAN1 mediated by SCFbeta-TrCP ubiquitin ligase.","date":"2008","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18575781","citation_count":17,"is_preprint":false},{"pmid":"23825664","id":"PMC_23825664","title":"NGF upregulates the plasminogen activation inhibitor-1 in neurons via the calcineurin/NFAT pathway and the Down syndrome-related proteins DYRK1A and RCAN1 attenuate this effect.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23825664","citation_count":17,"is_preprint":false},{"pmid":"15906378","id":"PMC_15906378","title":"Restoration of DSCR1 to disomy in the trisomy 16 mouse model of Down syndrome does not correct cardiac or craniofacial development anomalies.","date":"2005","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/15906378","citation_count":17,"is_preprint":false},{"pmid":"23150431","id":"PMC_23150431","title":"CREB-mediated Bcl-2 expression contributes to RCAN1 protection from hydrogen peroxide-induced neuronal death.","date":"2013","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23150431","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51291,"output_tokens":11862,"usd":0.165902,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":23315,"output_tokens":7166,"usd":0.147863,"stage2_stop_reason":"end_turn"},"total_usd":0.313765,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"RCAN1 (DSCR1) protein physically interacts with and inhibits calcineurin A (the catalytic subunit of PP2B). The binding region on calcineurin A is located in the linker region between the catalytic domain and the calcineurin B binding domain. Overexpression of RCAN1 inhibits calcineurin-dependent NFAT nuclear translocation and transcriptional activation.\",\n      \"method\": \"Co-immunoprecipitation, calcineurin phosphatase activity assay, NFAT nuclear translocation assay, overexpression in cell lines\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal binding demonstrated, enzymatic inhibition assay, multiple orthogonal methods, replicated across multiple subsequent studies\",\n      \"pmids\": [\"10861295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DSCR1 and DYRK1A act synergistically to prevent nuclear occupancy of NFATc transcription factors. Trisomy of both genes cooperatively destabilizes the calcineurin-NFAT regulatory circuit, leading to reduced NFATc activity. Mathematical modeling predicted that autoregulation within the pathway accentuates trisomy effects. Validated in calcineurin- and Nfatc-deficient mice, Dscr1- and Dyrk1a-overexpressing mice, and Down syndrome mouse models.\",\n      \"method\": \"Mathematical modeling, transgenic mouse models (Dscr1- and Dyrk1a-overexpressing), calcineurin/Nfatc knockout mice, Down syndrome mouse model analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal in vivo genetic models, quantitative modeling validated experimentally, replicated across labs\",\n      \"pmids\": [\"16554754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"A small peptide fragment of DSCR1 competitively inhibits calcineurin phosphatase activity in vitro and in vivo, blocking calcineurin-mediated NFAT nuclear localization.\",\n      \"method\": \"In vitro calcineurin phosphatase activity assay, in vivo NFAT nuclear localization assay, peptide fragment analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with defined peptide, in vivo validation, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"16131541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"RCAN1 interacts directly with TAB2, recruiting a macromolecular complex containing TAK1, TAB1, and calcineurin. TAK1 phosphorylates RCAN1 at Ser94 and Ser136, converting RCAN1 from an inhibitor to a facilitator of calcineurin-NFAT signaling. This enhances NFATc1 nuclear translocation and hypertrophic cardiomyocyte growth. Calcineurin activation conversely dephosphorylates and inhibits TAK1 and TAB1.\",\n      \"method\": \"Yeast two-hybrid screen, in vitro binding assay, Co-immunoprecipitation, in vitro phosphorylation assay, site-directed mutagenesis, Rcan1/2- and Tab2-deficient MEF cultures, calcineurin activity assay, NFAT transcriptional reporter\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — yeast two-hybrid, in vitro pulldown, reciprocal Co-IP, in vitro kinase assay with mutagenesis, KO cell validation, multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"19136967\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Dyrk1A directly interacts with and phosphorylates RCAN1 at Ser112 and Thr192. Phosphorylation at Ser112 primes RCAN1 for GSK3β-mediated phosphorylation at Ser108. Phosphorylation at Thr192 enhances RCAN1 binding to calcineurin, increasing calcineurin inhibition, reducing NFAT transcriptional activity, and enhancing tau phosphorylation. Dyrk1A-mediated phosphorylation also extends RCAN1 half-life.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis, Co-immunoprecipitation, calcineurin phosphatase activity assay, NFAT reporter assay, Western blot of Dyrk1A transgenic mouse brain\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with mutagenesis, multiple phosphorylation sites mapped, functional validation via calcineurin activity and NFAT reporter, in vivo validation in transgenic mice\",\n      \"pmids\": [\"21965663\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"RCAN1 isoform 1 (calcipressin 1) protects against acute oxidative stress and calcium-mediated stress through calcineurin inhibition. Protection increased as a function of RCAN1 expression and decreased when expression was reduced via antisense oligonucleotides.\",\n      \"method\": \"Stable RCAN1 transfection in HA-1 cells, tet-off regulated RCAN1 transgene in PC-12 cells, antisense oligonucleotides, H2O2 and calcium ionophore challenge, cross-adaptation assay\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple independent experimental systems (stable transfection, inducible transgene, antisense knockdown), dose-dependent relationship established\",\n      \"pmids\": [\"12039863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"DSCR1/RCAN1 overexpression suppresses tumor angiogenesis through inhibition of the calcineurin pathway in vascular endothelium, sufficient to suppress tumor growth in mice. Targeted deletion of both DSCR1 isoforms leads to hyperactivated calcineurin, precocious endothelial apoptosis, impaired tumor vasculature, and suppressed tumorigenesis. Calcineurin inhibition with cyclosporin A rescues this endothelial defect in DSCR1−/− mice.\",\n      \"method\": \"Transgenic Dscr1 mouse (single extra copy), DSCR1−/− knockout mice, tumor implantation models, cyclosporin A pharmacological rescue, VEGF-mediated calcineurin-NFAT pathway assays\",\n      \"journal\": \"Nature / Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic gain and loss of function in vivo, pharmacological rescue, replicated across two independent Nature/Cancer Cell publications\",\n      \"pmids\": [\"19458618\", \"18455125\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"DSCR1/RCAN1 expression in endothelial cells blocks dephosphorylation, nuclear translocation, and transcriptional activity of NFAT (downstream of calcineurin). DSCR1 is most significantly induced by VEGF in a genome-wide analysis. Knockdown of endogenous DSCR1 increases NFAT activity and stimulates inflammatory gene expression (tissue factor, E-selectin, Cox-2).\",\n      \"method\": \"Genome-wide gene expression analysis, DSCR1 overexpression in endothelial cells, NFAT nuclear translocation assay, siRNA knockdown of DSCR1, inflammatory marker gene expression\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide screen combined with overexpression and siRNA knockdown, NFAT functional readout, multiple orthogonal methods\",\n      \"pmids\": [\"15016650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RCAN1 knockout mice exhibit increased calcineurin enzymatic activity, increased abundance of a cleaved calcineurin fragment, decreased phosphorylation of DARPP-32 (a calcineurin substrate), and deficits in spatial learning, associative memory, and late-phase LTP—phenotypes consistent with excess calcineurin signaling.\",\n      \"method\": \"RCAN1 knockout mouse, calcineurin activity assay, DARPP-32 phosphorylation western blot, behavioral testing (Morris water maze, fear conditioning), electrophysiology (L-LTP)\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined molecular (calcineurin activity, substrate phosphorylation) and cellular phenotypes (LTP, behavior), multiple orthogonal readouts\",\n      \"pmids\": [\"18045910\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"RCAN1 protein is degraded by both the ubiquitin-proteasome pathway and chaperone-mediated autophagy (CMA) through a CMA-lysosome pathway. Two CMA recognition motifs were identified in RCAN1. Inhibition of CMA increased RCAN1 expression. Inhibition of RCAN1 degradation reduced calcineurin-NFAT activity.\",\n      \"method\": \"Lysosomal inhibitors, macroautophagy inhibition, CMA disruption, promoter assay for calcineurin-NFAT activity, identification of CMA recognition motifs\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple degradation pathway inhibitors, CMA motif identification, functional consequence on calcineurin-NFAT, single lab\",\n      \"pmids\": [\"19509306\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"RCAN1 is a novel ATF6-inducible gene. Activated ATF6 induces the RCAN1 promoter, upregulates RCAN1 mRNA, inhibits calcineurin phosphatase activity, and exerts a growth-modulating effect in cardiac myocytes that is blocked by RCAN1-targeted siRNA.\",\n      \"method\": \"Transgenic ATF6 mouse model, transcript profiling, adenoviral ATF6 overexpression in cardiac myocytes, RCAN1 promoter-luciferase assay, calcineurin activity assay, siRNA knockdown\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo transgenic model, cell culture mechanistic follow-up with siRNA rescue, calcineurin activity readout, multiple orthogonal methods\",\n      \"pmids\": [\"18319259\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"RCAN1 overexpression (via tet-off RCAN1 transgene) inhibits calcineurin (PP2B), leading to increased tau phosphorylation by GSK3β and significantly inhibiting tau degradation by the proteasome in PC12 cells.\",\n      \"method\": \"Tet-off RCAN1 transgene in PC12 cells, in vitro 20S proteasome degradation assay with recombinant tau, GSK3β phosphorylation assay, okadaic acid and cyclosporin A pharmacological comparisons\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution of tau degradation by purified 20S proteasome, inducible transgene system, pharmacological controls, multiple orthogonal approaches\",\n      \"pmids\": [\"16939415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Regulated overexpression of an RCAN1 transgene stimulates expression of GSK3β kinase at a post-transcriptional level. RCAN1-1S isoform levels specifically correlate with GSK3β levels in human brain. This positions RCAN1 as a regulator of both calcineurin and the opposing kinase GSK3β.\",\n      \"method\": \"Regulated RCAN1 transgene expression, Western blotting for GSK3β protein, mRNA analysis (post-transcriptional mechanism), human brain tissue analysis\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — inducible transgene, mRNA vs protein comparison establishing post-transcriptional mechanism, correlation in human tissue, single lab\",\n      \"pmids\": [\"16649988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Amyloid-β upregulates RCAN1 expression in cortical neurons via Aβ-induced oxidative stress. Increased RCAN1 both inhibits calcineurin (reducing tau dephosphorylation) and upregulates GSK3β (increasing tau phosphorylation), together causing tau hyperphosphorylation. Silencing RCAN1 or adding antioxidants prevented Aβ-induced tau hyperphosphorylation.\",\n      \"method\": \"Primary fetal rat cortical neuron culture with Aβ treatment, RCAN1 siRNA knockdown, antioxidant treatment, tau phosphorylation western blot, calcineurin activity assay, GSK3β expression analysis\",\n      \"journal\": \"Journal of Alzheimer's disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA rescue of molecular phenotype, multiple readouts, single lab, in vitro only\",\n      \"pmids\": [\"21876249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RCAN1-1 overexpression in primary neurons activates caspase-9 and caspase-3, inducing neuronal apoptosis. A functional glucocorticoid response element was identified in the RCAN1 isoform 1 promoter mediating stress-induced upregulation. Neurotoxicity of RCAN1-1 is blocked in caspase-3−/− neurons.\",\n      \"method\": \"Overexpression in primary neurons, caspase-3/9 activation assay, caspase-3 knockout neurons, glucocorticoid response element identification in RCAN1-1 promoter, dexamethasone treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic rescue (caspase-3 KO), promoter functional analysis, apoptosis mechanistic pathway established, single lab\",\n      \"pmids\": [\"21216952\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"RCAN1 regulates vesicle exocytosis in chromaffin cells: Rcan1 loss or overexpression both reduced the number of vesicles undergoing exocytosis. Increasing Rcan1 expression reduced catecholamine released per vesicle and altered fusion pore kinetics. Acute calcineurin inhibition did not replicate the effect of RCAN1 overexpression, indicating a calcineurin-independent mechanism for fusion pore regulation.\",\n      \"method\": \"RCAN1 overexpressing and knockout mouse chromaffin cells, carbon fibre amperometry, Ca2+ entry measurements, readily releasable pool size assay, acute calcineurin inhibitor comparison\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic gain and loss of function, quantitative single-vesicle amperometry, negative result (calcineurin inhibition does not mimic) mechanistically informative, single lab\",\n      \"pmids\": [\"18180251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"RCAN1-1L induction causes dramatic degradation of mitochondria (mitophagy) involving the adenine nucleotide translocator and mitochondrial permeability transition pore opening, and shifts cellular bioenergetics from aerobic respiration to glycolysis.\",\n      \"method\": \"Inducible RCAN1-1L expression in neuronal cells, mitochondrial mass/morphology analysis, ANT and mPTP involvement assays, cellular bioenergetics measurement (oxygen consumption vs glycolysis)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — inducible transgene system, mechanistic dissection of ANT/mPTP pathway, bioenergetics assays, single lab\",\n      \"pmids\": [\"22389495\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"RCAN1 (triplicated in Down syndrome) inhibits TrkA receptor endocytosis downstream of calcineurin phosphatase, impairing NGF-dependent neurotrophin trafficking, neuronal survival, and sympathetic innervation. Genetically correcting RCAN1 levels in Down syndrome mice restored NGF-dependent receptor trafficking and neuronal survival.\",\n      \"method\": \"Down syndrome mouse model, RCAN1 genetic correction, TrkA receptor internalization assay, retrograde NGF trafficking assay, sympathetic innervation quantification, neuronal survival assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic rescue experiment in DS mouse model, receptor trafficking directly measured, multiple in vivo readouts, mechanistically placed in calcineurin pathway\",\n      \"pmids\": [\"26658127\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"RCAN1 maintains a more fused mitochondrial network by inhibiting calcineurin-dependent activation of the fission protein DRP1. When RCAN1 is depleted, calcineurin activates DRP1, leading to mitochondrial fragmentation, reduced membrane potential, reduced O2 consumption, and impaired mitochondrial Ca2+ buffering. Pharmacological inhibition of calcineurin, DRP1, or calpains (CAPN) restored protection in RCAN1-depleted cardiomyocytes.\",\n      \"method\": \"RCAN1 KO cardiomyocytes, adenoviral RCAN1 overexpression, DRP1 phosphorylation assay, mitochondrial morphology imaging, pharmacological inhibitors (calcineurin, DRP1, calpain), Down syndrome iPSC disomic/trisomic comparison\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO and gain of function, pharmacological rescue with pathway-specific inhibitors, human DS iPSC validation, multiple orthogonal methods\",\n      \"pmids\": [\"29362227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"RCAN1 (DSCR1) interacts with FMRP and regulates dendritic spine morphogenesis and local protein synthesis. Decreasing FMRP levels restores DSCR1-induced changes in dendritic spine morphology.\",\n      \"method\": \"Co-immunoprecipitation of DSCR1 and FMRP, dendritic spine morphology analysis, local protein synthesis assay, FMRP knockdown rescue experiment\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, genetic rescue (FMRP knockdown), spine morphology and local synthesis phenotypes, single lab\",\n      \"pmids\": [\"22863780\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"RCAN1 (DSCR1) controls axon outgrowth by modulating growth cone actin dynamics through regulation of cofilin phosphorylation/dephosphorylation. RCAN1 also mediates BDNF-induced local protein synthesis and growth cone turning.\",\n      \"method\": \"DSCR1 loss-of-function in neurons, phospho-cofilin/cofilin ratio measurement, live-imaging of axon outgrowth, BDNF-induced growth cone turning assay, local protein synthesis assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with defined molecular readout (cofilin phosphorylation), axon growth and turning assays, single lab\",\n      \"pmids\": [\"27185837\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RCAN1 binds to TET1 introns and regulates TET1 splicing, thereby modulating TET1 protein levels. TET1 controls demethylation of the miR-124 promoter to regulate miR-124 expression, which in turn controls adult hippocampal neurogenesis. Correcting TET1 levels in RCAN1 KO mice prevents defective adult neurogenesis.\",\n      \"method\": \"RCAN1 KO mice, RNA-binding/splicing assay (RCAN1-TET1 interaction), miR-124 promoter methylation analysis, adult neurogenesis quantification, genetic rescue (TET1 correction in RCAN1 KO), Down syndrome mouse model rescue\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse with defined molecular pathway (TET1 splicing → miR-124 → neurogenesis), genetic rescue, novel non-calcineurin mechanism, single lab\",\n      \"pmids\": [\"31304631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RCAN1 GSK3β nuclear export switches RCAN1 from a calcineurin inhibitor to a facilitator of calcineurin-NFAT signaling in a dose-dependent manner. PI3K signaling promotes GSK3β nuclear export, enabling the facilitatory role. Sequential phosphorylation of RCAN1 mediates this switch.\",\n      \"method\": \"Single-cell experimentation, mathematical modeling, PI3K inhibitor treatment, GSK3β nuclear export assay, NFAT reporter assay, dose-response analysis\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — computational modeling validated by single-cell experiments and pharmacological perturbation, dose-dependent mechanistic switch identified, single lab\",\n      \"pmids\": [\"21172821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Raf-1 is a direct binding partner of DSCR1. Two Raf-1 binding regions were identified in DSCR1 (N-terminus and C-terminus). Calpain cleaves DSCR1 and generates fragments with differential binding affinity to Raf-1 versus calcineurin.\",\n      \"method\": \"Pulldown assay with DSCR1 as bait, co-immunoprecipitation in GFP-DSCR1 expressing cells, deletion mapping of binding regions, calpain cleavage assay\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — pulldown and Co-IP, domain mapping, calpain cleavage experiment, single lab, no functional consequence of Raf-1 binding established\",\n      \"pmids\": [\"15935327\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"RCAN1-1L promotes CREB phosphorylation and cAMP response element-mediated gene transcription. This effect is dependent on RCAN1's ability to inhibit calcineurin. RCAN1 induces Bcl-2 expression via CREB activation, protecting neurons from H2O2-induced apoptosis. RCAN1 inhibits H2O2-induced MAPK and AP-1 activation.\",\n      \"method\": \"RCAN1 overexpression and shRNA knockdown in neuronal cells, CREB phosphorylation western blot, CRE-luciferase reporter assay, Bcl-2 expression analysis, H2O2 cytotoxicity assay, calcineurin inhibitor comparison\",\n      \"journal\": \"The Journal of biological chemistry / Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain and loss of function, calcineurin-dependence established, CREB/Bcl-2 pathway mechanistically linked, single lab\",\n      \"pmids\": [\"21890628\", \"23150431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"CREB activates proteasomal degradation of RCAN1 via the ubiquitin-proteasome pathway. CREB-enhanced ubiquitination of RCAN1 increases its turnover rate. This regulatory function depends on CREB's transcriptional activation.\",\n      \"method\": \"Proteasome inhibitor treatment, ubiquitination assay, RCAN1 protein turnover (pulse-chase), CREB overexpression and transcriptional activation mutants\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — proteasome inhibitors, ubiquitination assay, transcriptional activation mutant, single lab\",\n      \"pmids\": [\"18485898\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Oxidative stress (H2O2) induces ubiquitination of RCAN1 mediated by SCFβ-TrCP ubiquitin ligase. β-TrCP interacts with RCAN1 in an H2O2-dependent manner. In vitro ubiquitination assay showed SCFβ-TrCP (but not SCFFBW4) ubiquitinates RCAN1 in response to H2O2. Knockdown of β-TrCP abolished H2O2-induced RCAN1 decrease in cells and primary neurons.\",\n      \"method\": \"Co-immunoprecipitation of β-TrCP and FBW4 with RCAN1, in vitro ubiquitination assay, siRNA knockdown of β-TrCP, primary hippocampal and cortical neuron experiments\",\n      \"journal\": \"International journal of molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro ubiquitination reconstitution, Co-IP, siRNA rescue, validated in primary neurons, single lab\",\n      \"pmids\": [\"18575781\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NEDD8 is covalently conjugated to RCAN1-1S at lysine residues K96, K104, and K107. Neddylation enhances RCAN1 protein stability by inhibiting proteasomal degradation, increases RCAN1 binding to calcineurin, and potentiates its inhibitory activity toward downstream NFAT signaling.\",\n      \"method\": \"NEDD8 conjugation mapping to K96/K104/K107 by mutagenesis, protein stability assay, Co-immunoprecipitation of neddylated RCAN1 with calcineurin, NFAT reporter assay, proteasome inhibitor comparison\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — PTM site mapping by mutagenesis, stability assay, binding and functional assay, single lab\",\n      \"pmids\": [\"23118980\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Oxidative stress (H2O2, peroxynitrite, menadione) induces hyperphosphorylation of DSCR1/RCAN1 protein. Phosphorylation of serines in a 13-amino acid calcineurin-interacting conserved region of DSCR1 attenuates its inhibition of calcineurin.\",\n      \"method\": \"H2O2 and oxidant treatment of human cells, gel mobility shift analysis, kinase inhibitor panel, phosphopeptide synthesis and calcineurin inhibition assay\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro calcineurin assay with phosphopeptides, multiple oxidants tested, single lab\",\n      \"pmids\": [\"12927602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"DSCR1/RCAN1 protein localizes preferentially to the nucleus, independently of isoform, cell line, or GFP orientation. A C-terminal segment is important for nuclear localization. Site-directed mutagenesis indicates serine and threonine residues contribute to nuclear targeting, suggesting phosphorylation regulates localization.\",\n      \"method\": \"GFP fusion protein imaging in multiple cell lines, deletion mutagenesis, site-directed mutagenesis of serine/threonine residues\",\n      \"journal\": \"BMC cell biology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — GFP localization assay with deletion and point mutagenesis, multiple cell lines, but no direct functional consequence of localization demonstrated\",\n      \"pmids\": [\"12225619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In Drosophila, the RCAN1 ortholog sarah (sra) is required for normal sleep. Sleep reduction in sra mutants correlates with decreased Sra protein levels. Pan-neural sra expression rescues the sleep phenotype. Calcineurin (CanA-14F and CanB subunits) loss also reduces sleep, and sra sleep defects are suppressed by calcineurin mutations, establishing that sra and calcineurin affect sleep through a common mechanism.\",\n      \"method\": \"Drosophila sra mutants, calcineurin subunit knockout mutants, pan-neural transgenic rescue, constitutively active calcineurin expression, epistasis analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Drosophila ortholog (RCAN family), genetic epistasis establishing common pathway, multiple calcineurin subunit knockouts, transgenic rescue, clean behavioral phenotype with molecular pathway assignment\",\n      \"pmids\": [\"21900555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Increased dosage of DSCR1 and DYRK1A in neocortical progenitor cells cooperatively suppresses NFATc activity, delaying neuronal differentiation and altering laminar fate in the developing neocortex. Counteracting the dysregulated pathway ameliorates delayed neuronal differentiation in the Ts1Cje Down syndrome mouse model.\",\n      \"method\": \"In utero electroporation for DYRK1A and DSCR1 overexpression in neocortex, Ts1Cje DS mouse model, NFATc activity assay, neuronal differentiation and laminar fate analysis, pathway rescue\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo neural progenitor experiments with pathway rescue, DS mouse model validation, NFATc mechanistic link established, multiple orthogonal approaches\",\n      \"pmids\": [\"24352425\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"RCAN1 overexpression in β-cells causes mitochondrial dysfunction including hyperpolarized membrane potential, reduced oxidative phosphorylation, and low ATP production. This impairs both glucose-stimulated membrane depolarization and ATP-dependent insulin granule exocytosis, causing hypoinsulinemia.\",\n      \"method\": \"RCAN1-overexpressing mice, in vivo glucose-stimulated insulin secretion test, β-cell mitochondrial membrane potential measurement, oxidative phosphorylation assay, ATP production measurement, insulin granule exocytosis assay\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic mouse model with multiple mechanistic readouts, direct measurement of mitochondrial parameters, single lab\",\n      \"pmids\": [\"27195491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"VEGF induces RCAN1.4 expression in endothelial cells via Ca2+/calcineurin and protein kinase C-delta (PKC-δ) pathways. siRNA knockdown of RCAN1.4 results in decreased cell migration and disrupted tubular morphogenesis. RCAN1.4 knockdown increases NFAT-regulated gene expression, confirming a negative feedback role on calcineurin-NFAT signaling.\",\n      \"method\": \"PKC and calcineurin inhibitors, siRNA silencing of PKC-δ and RCAN1.4, RCAN1.4 promoter assay, NFAT target gene expression, endothelial cell migration assay, collagen gel tubulogenesis assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown, pathway inhibitors, functional cellular assays (migration, tubulogenesis), NFAT reporter, single lab\",\n      \"pmids\": [\"20625401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"RCAN1.4 regulates VEGFR-2 internalization (agonist-stimulated receptor endocytosis) and establishment of endothelial cell polarity in response to VEGF. RCAN1.4 is required for efficient VEGF-mediated cytoskeletal reorganization, directed cell migration, and sprouting angiogenesis. Morpholino silencing of zebrafish RCAN1.4 orthologue disrupted vascular development in vivo.\",\n      \"method\": \"siRNA-mediated knockdown, adenoviral RCAN1.4 overexpression, VEGFR-2 internalization assay, cell polarity assay, cytoskeletal imaging, directed cell migration, sprouting assay, zebrafish morpholino knockdown\",\n      \"journal\": \"Angiogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA and overexpression in human cells, in vivo zebrafish validation, VEGFR-2 internalization directly measured, single lab\",\n      \"pmids\": [\"28271280\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"RCAN1 (Rcan1) negatively regulates FcεRI-mediated mast cell activation. Rcan1-deficient mast cells show increased calcineurin activity, increased NFAT and NF-κB activation, and increased cytokine production and degranulation. Egr1 transcription factor controls Rcan1 expression through a functional Egr1 binding site in the RCAN1 promoter. Forced expression of Rcan1 in Rcan1-deficient mast cells reduced cytokine production.\",\n      \"method\": \"Rcan1 KO mast cells, calcineurin activity assay, NFAT and NF-κB reporter assays, cytokine ELISA, passive cutaneous anaphylaxis in vivo, Egr1 promoter analysis, ChIP, Rcan1 reconstitution in KO cells\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO with reconstitution, calcineurin activity directly measured, multiple signaling readouts, in vivo anaphylaxis model, promoter mechanism identified\",\n      \"pmids\": [\"19124655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"RCAN1 deficiency reduces atherosclerosis severity in Apoe−/− mice. Rcan1 regulates CD36 expression in macrophages, and its inactivation reduces oxLDL uptake, resistance to oxLDL-mediated inhibition of macrophage migration, and increases anti-inflammatory markers. Bone marrow transplantation of Apoe−/−Rcan1−/− cells into Apoe−/− recipients confers atherosclerosis resistance, demonstrating the effect is hematopoietic cell-autonomous.\",\n      \"method\": \"Apoe−/−Rcan1−/− double-knockout mice, bone marrow transplantation, CD36 expression assay, oxLDL uptake assay, macrophage migration assay, atherosclerosis lesion quantification\",\n      \"journal\": \"EMBO molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO in disease model, bone marrow transplantation for cell autonomy, CD36 and oxLDL uptake mechanistically linked, single lab\",\n      \"pmids\": [\"24127415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"RCAN1 overexpression promotes DRP1-mediated mitochondrial fission and age-dependent tau pathology. Brain-specific overexpression of human RCAN1.1S induces memory and synaptic plasticity deficits, tau pathology, and dysregulation of DRP1 activity associated with mitochondrial dysfunction and oxidative stress.\",\n      \"method\": \"Brain-specific RCAN1.1S transgenic mice, DRP1 activity assay, mitochondrial morphology analysis, behavioral testing, synaptic plasticity electrophysiology, tau pathology immunostaining\",\n      \"journal\": \"Acta neuropathologica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic mouse model with molecular readout (DRP1 activity, tau phosphorylation), behavioral and electrophysiology phenotypes, mechanistic pathway proposed, single lab\",\n      \"pmids\": [\"26497675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"RCAN1 knockdown rescues Huntington's disease patient-derived striatal neurons (MSNs) from degeneration by enhancing calcineurin activity, leading to TFEB nuclear localization through dephosphorylation and activation of autophagy/longevity gene chromatin accessibility. A glibenclamide analog (G2-115) reduces RCAN1-calcineurin interaction, phenocopying RCAN1 knockdown.\",\n      \"method\": \"Direct neuronal reprogramming of human fibroblasts to MSNs, longitudinal transcriptomics, RCAN1 knockdown (siRNA/shRNA), calcineurin activity assay, TFEB nuclear localization assay, chromatin accessibility (ATAC-seq), pharmacological G2-115 treatment\",\n      \"journal\": \"Nature aging\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — human patient-derived neurons, siRNA rescue, TFEB dephosphorylation and nuclear translocation directly measured, pharmacological mimicry, multiple orthogonal methods, rigorous study\",\n      \"pmids\": [\"38066314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"LRRK2 kinase phosphorylates RCAN1-1S and is upregulated during IL-1β treatment. LRRK2-mediated phosphorylation of RCAN1 promotes formation of Tollip-RCAN1 protein complexes, decreases Tollip-IRAK1 interaction, increases IRAK1-TRAF6 complex formation, enhances TAK1 activity, and promotes NF-κB transcriptional activity and IL-8 production.\",\n      \"method\": \"In vitro kinase assay, co-immunoprecipitation, NF-κB reporter assay, IL-8 ELISA, LRRK2 and RCAN1 overexpression/knockdown\",\n      \"journal\": \"Frontiers in cellular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro kinase assay, Co-IP, NF-κB functional reporter, cytokine readout, single lab\",\n      \"pmids\": [\"28553204\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"C/EBPβ directly binds to multiple conserved sites in the RCAN1-4 promoter and cooperates with NFAT to regulate RCAN1-4 expression. A direct protein-protein interaction between C/EBPβ and NFAT was demonstrated, and complex formation occurs at NFAT-C/EBPβ composite sites. Depletion of C/EBPβ decreased maximal RCAN1-4 activation by calcineurin. C/EBPβ occupancy of Rcan1-4 promoter increased in mouse models of heart failure.\",\n      \"method\": \"EMSA (electrophoretic mobility shift assay), chromatin immunoprecipitation (ChIP), co-immunoprecipitation of C/EBPβ and NFAT, RCAN1-4 luciferase reporter, C/EBPβ depletion, heart failure mouse model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA, ChIP, Co-IP, functional reporter, in vivo heart failure validation, single lab\",\n      \"pmids\": [\"20371871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RCAN1.4 expression is epigenetically suppressed by DNA methylation mediated by DNMT1 and DNMT3b, as shown by ChIP assay. RCAN1.4 overexpression alleviates liver fibrosis by inhibiting CaN/NFAT3 signaling. Knockdown of RCAN1.4 exacerbates TGF-β1-induced liver fibrosis in a CaN/NFAT3-dependent manner.\",\n      \"method\": \"Bisulfite sequencing PCR, ChIP assay with DNMT1/DNMT3b, 5-azadC demethylation, rAAV8-RCAN1.4 in vivo delivery, CaN/NFAT3 reporter and activity assay, liver fibrosis mouse model\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP identifying specific methyltransferases, in vivo AAV rescue, CaN/NFAT3 mechanistic link, single lab\",\n      \"pmids\": [\"31285763\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RCAN1 (DSCR1) is an endogenous inhibitor of the Ca2+/calmodulin-dependent phosphatase calcineurin that binds directly to calcineurin's linker region to block its phosphatase activity, thereby preventing NFAT dephosphorylation and nuclear translocation; this inhibitory activity is bidirectionally regulated by phosphorylation (TAK1 at Ser94/Ser136 converts RCAN1 to a calcineurin facilitator; Dyrk1A at Thr192 enhances calcineurin inhibition; GSK3β and oxidative-stress-induced phosphorylation attenuate inhibition), by post-translational modification (neddylation stabilizes and potentiates; SCFβ-TrCP ubiquitination and CREB-driven proteasomal degradation reduce RCAN1 levels; CMA-lysosomal degradation also controls abundance), and by isoform-specific expression driven by alternative promoters (RCAN1-4 induced by calcineurin-NFAT feedback; RCAN1-1 by glucocorticoids and oxidative stress; both regulated by ATF6, C/EBPβ, AP-1, and DNMT-mediated methylation); beyond calcineurin, RCAN1 interacts with FMRP to regulate dendritic spine morphology and local protein synthesis, with TET1 to control epigenetic regulation of adult neurogenesis, with TAB2 to form a TAK1-TAB1-TAB2-calcineurin signaling complex, with Raf-1, and with IκBα to modulate NF-κB; at the organelle level RCAN1 restrains calcineurin-dependent DRP1 activation to maintain mitochondrial fusion, and regulates vesicle fusion pore kinetics and exocytosis in a partially calcineurin-independent manner; collectively, these mechanisms position RCAN1 as a context-dependent regulator of calcineurin-NFAT signaling whose dysregulation contributes to Down syndrome cognitive deficits, Alzheimer's-associated tau hyperphosphorylation, tumor angiogenesis suppression, cardiac hypertrophy, β-cell dysfunction, and neurotrophin trafficking.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"RCAN1 (DSCR1) is an endogenous regulator of the Ca2+/calmodulin-dependent phosphatase calcineurin that governs the calcineurin–NFAT signaling axis across cardiovascular, neuronal, immune, and metabolic contexts [#0, #6, #35]. It binds calcineurin A directly at the linker region between the catalytic and calcineurin-B-binding domains, and a short peptide spanning its conserved calcineurin-interacting region competitively inhibits phosphatase activity, blocking NFAT dephosphorylation, nuclear translocation, and transcription [#0, #2]. Loss of RCAN1 elevates calcineurin activity in vivo, producing excess substrate dephosphorylation and phenotypes from defective spatial learning and late-phase LTP to hyperactivated endothelial and mast-cell signaling [#8, #35, #6]. Its activity is not fixed but switched by phosphorylation: Dyrk1A phosphorylation at Thr192 strengthens calcineurin binding and inhibition while extending RCAN1 half-life, whereas TAK1 phosphorylation at Ser94/Ser136—following RCAN1 binding to TAB2 and recruitment of a TAK1–TAB1–calcineurin complex—and GSK3β nuclear export convert RCAN1 from inhibitor to facilitator of NFAT signaling; oxidative-stress-induced phosphorylation of its conserved region attenuates inhibition [#3, #4, #22, #28]. RCAN1 abundance is set by opposing post-translational controls—neddylation at K96/K104/K107 stabilizes and potentiates it, while SCFβ-TrCP ubiquitination, CREB-driven proteasomal turnover, and chaperone-mediated autophagy degrade it—and by isoform-specific transcription through ATF6, C/EBPβ/NFAT feedback, Egr1, glucocorticoid response elements, and DNMT-mediated methylation [#27, #26, #25, #9, #10, #40, #35, #14, #41]. Functionally, RCAN1 dosage controls tumor and developmental angiogenesis via endothelial calcineurin-NFAT and VEGFR-2 trafficking [#6, #7, #34], restrains calcineurin-dependent DRP1 activation to preserve mitochondrial fusion [#18], and cooperates with DYRK1A to suppress NFATc during neocortical development, a Down syndrome-relevant circuit [#1, #31]. Beyond calcineurin, RCAN1 interacts with FMRP to regulate dendritic spine morphology and local protein synthesis, with TET1 to control miR-124-dependent adult neurogenesis, and modulates vesicle fusion-pore kinetics in a partially calcineurin-independent manner [#19, #21, #15]. RCAN1 dysregulation drives calcineurin-dependent disease, including Down syndrome neurotrophin-trafficking and differentiation deficits, Alzheimer's-associated tau hyperphosphorylation through combined calcineurin inhibition and GSK3β upregulation, and Huntington's striatal neurodegeneration where RCAN1 knockdown restores calcineurin-TFEB-autophagy signaling [#17, #13, #38].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Established that RCAN1 is a direct calcineurin-binding inhibitor, defining its core molecular activity and the calcineurin-NFAT axis it controls.\",\n      \"evidence\": \"Co-IP, calcineurin phosphatase assay, and NFAT translocation assay with overexpression in cell lines\",\n      \"pmids\": [\"10861295\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding region mapped to the calcineurin linker but no structural model of the complex\", \"Endogenous regulation not yet addressed by overexpression alone\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Showed that RCAN1-mediated calcineurin inhibition is cytoprotective, linking abundance to resistance against oxidative and calcium stress.\",\n      \"evidence\": \"Stable and inducible transgene plus antisense knockdown in HA-1/PC-12 cells under H2O2 and ionophore challenge\",\n      \"pmids\": [\"12039863\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Protective downstream effectors not defined\", \"Isoform-specific contributions not separated\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Defined the minimal inhibitory unit, showing a short RCAN1 peptide competitively blocks calcineurin, supporting a defined enzymatic mechanism.\",\n      \"evidence\": \"In vitro and in vivo phosphatase and NFAT localization assays with peptide fragment\",\n      \"pmids\": [\"16131541\", \"15935327\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Raf-1 binding (15935327) lacks a defined functional consequence\", \"Competition mode versus the full-length protein not fully resolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Placed RCAN1 in a VEGF-driven endothelial negative-feedback loop, establishing a physiological inducer and an anti-inflammatory role for its calcineurin inhibition.\",\n      \"evidence\": \"Genome-wide expression, overexpression, and siRNA knockdown in endothelial cells with NFAT and inflammatory gene readouts\",\n      \"pmids\": [\"15016650\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Promoter elements driving VEGF induction not mapped here\", \"In vivo vascular relevance addressed only later\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrated cooperative dosage effects of RCAN1 and DYRK1A on NFATc, providing a quantitative model for how trisomy destabilizes calcineurin-NFAT signaling.\",\n      \"evidence\": \"Mathematical modeling validated in calcineurin/Nfatc-deficient, overexpressing, and Down syndrome mouse models\",\n      \"pmids\": [\"16554754\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct biochemical interplay of the two gene products not dissected\", \"Tissue-specific thresholds not defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Connected RCAN1 to tau pathology, showing it both inhibits calcineurin and upregulates GSK3β to promote tau phosphorylation and block proteasomal tau degradation.\",\n      \"evidence\": \"Tet-off RCAN1 transgene in PC12 cells, in vitro 20S proteasome degradation assay, GSK3β analysis, and human brain correlation\",\n      \"pmids\": [\"16939415\", \"16649988\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of post-transcriptional GSK3β upregulation unresolved\", \"In vivo tau consequences not yet tested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified transcriptional and ubiquitin-proteasome controls of RCAN1 abundance, showing ATF6 induces it and CREB and SCFβ-TrCP target it for degradation.\",\n      \"evidence\": \"ATF6 transgenic mice and promoter assays; proteasome inhibitor, ubiquitination, pulse-chase, and in vitro SCFβ-TrCP reconstitution\",\n      \"pmids\": [\"18319259\", \"18485898\", \"18575781\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Interplay between competing degradation routes not integrated\", \"Single-lab biochemistry for several degradation findings\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showed oxidative stress phosphorylates the conserved calcineurin-interacting region of RCAN1, attenuating inhibition and defining redox-sensitive regulation of activity.\",\n      \"evidence\": \"Oxidant treatment, gel mobility shift, kinase inhibitor panel, and phosphopeptide calcineurin assays\",\n      \"pmids\": [\"12927602\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Responsible kinase(s) not definitively assigned\", \"Phosphosite stoichiometry in cells unquantified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Provided genetic proof that endogenous RCAN1 restrains calcineurin in the brain, linking its loss to substrate hyperdephosphorylation and learning/LTP deficits.\",\n      \"evidence\": \"RCAN1 KO mice with calcineurin activity, DARPP-32 phosphorylation, behavioral, and electrophysiology assays\",\n      \"pmids\": [\"18045910\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell types responsible for behavioral deficits not isolated\", \"Cleaved calcineurin fragment origin unexplained\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Revealed the TAK1-driven inhibitor-to-facilitator switch, showing RCAN1–TAB2 recruits a TAK1–TAB1–calcineurin complex and Ser94/Ser136 phosphorylation reverses RCAN1's role.\",\n      \"evidence\": \"Yeast two-hybrid, in vitro binding and kinase assays, mutagenesis, KO MEFs, and NFAT reporter in cardiomyocyte hypertrophy\",\n      \"pmids\": [\"19136967\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo cardiac requirement of the switch not established here\", \"Structural basis of the multiprotein complex unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Extended RCAN1 turnover control to chaperone-mediated autophagy and broadened its immune role as an Egr1-controlled brake on FcεRI-mediated mast cell activation.\",\n      \"evidence\": \"CMA/lysosome inhibitor and motif analysis; Rcan1 KO mast cells with reconstitution, calcineurin/NFAT/NF-κB readouts, ChIP, and anaphylaxis model\",\n      \"pmids\": [\"19509306\", \"19124655\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative flux through CMA versus proteasome in vivo unclear\", \"Direct NF-κB regulation mechanism not fully defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Mapped Dyrk1A and GSK3β phosphorylation as the molecular tuner of RCAN1, with Thr192 enhancing calcineurin inhibition and GSK3β nuclear export enabling the facilitatory state.\",\n      \"evidence\": \"In vitro kinase assays, mutagenesis, Co-IP, calcineurin/NFAT assays, single-cell modeling, and PI3K inhibition\",\n      \"pmids\": [\"21965663\", \"21172821\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative thresholds dictating inhibitor versus facilitator state in vivo unknown\", \"Cross-talk with TAK1-mediated switch not integrated\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Linked stress-induced RCAN1-1 to neuronal apoptosis and tau pathology, showing a glucocorticoid response element and Aβ/oxidative-stress induction converge on caspase activation and tau hyperphosphorylation.\",\n      \"evidence\": \"Primary neuron overexpression and siRNA, caspase assays, caspase-3 KO rescue, GRE identification, and Aβ/antioxidant treatments\",\n      \"pmids\": [\"21216952\", \"21876249\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance to Alzheimer's progression not tested\", \"Single-lab in vitro neuronal systems\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Established neddylation as a stabilizing, potentiating modification and uncovered RCAN1 protein-protein roles beyond calcineurin via FMRP at dendritic spines and CREB-Bcl-2 survival signaling.\",\n      \"evidence\": \"NEDD8 site mapping and stability/binding assays; FMRP Co-IP with spine and local-synthesis rescue; CREB/Bcl-2 reporter and H2O2 cytotoxicity assays\",\n      \"pmids\": [\"23118980\", \"22863780\", \"21890628\", \"23150431\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"NEDD8 conjugating machinery for RCAN1 not identified\", \"FMRP-dependent function not mechanistically separated from calcineurin\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Connected RCAN1 to mitochondrial and vesicular physiology, showing RCAN1-1L drives mitophagy/bioenergetic shift and that fusion-pore regulation is partly calcineurin-independent.\",\n      \"evidence\": \"Inducible RCAN1-1L in neuronal cells with ANT/mPTP and bioenergetic assays; chromaffin-cell amperometry in KO/overexpressing mice\",\n      \"pmids\": [\"22389495\", \"18180251\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Calcineurin-independent fusion-pore effector unidentified\", \"Mechanism coupling RCAN1 to ANT/mPTP unresolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrated developmental and atherosclerotic roles, with RCAN1/DYRK1A suppressing NFATc in neocortical progenitors and RCAN1 regulating macrophage CD36 and oxLDL uptake.\",\n      \"evidence\": \"In utero electroporation and Ts1Cje rescue; Apoe-/-Rcan1-/- mice with bone marrow transplantation and CD36/oxLDL assays\",\n      \"pmids\": [\"24352425\", \"24127415\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct calcineurin dependence of CD36 regulation not established\", \"Neuronal versus vascular dosage effects not unified\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showed RCAN1 dosage controls NGF/TrkA neurotrophin trafficking and, when overexpressed, drives DRP1-mediated fission with tau pathology, mechanistically linking it to Down syndrome and tauopathy.\",\n      \"evidence\": \"Down syndrome mouse genetic correction with TrkA internalization and survival assays; brain-specific RCAN1.1S transgenic mice with DRP1, behavioral, and tau readouts\",\n      \"pmids\": [\"26658127\", \"26497675\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which RCAN1 controls receptor endocytosis only partly defined\", \"Reconciliation of fission (overexpression) versus fusion (depletion) phenotypes incomplete\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Extended RCAN1 mitochondrial control to β-cells, showing overexpression impairs oxidative phosphorylation, ATP production, and glucose-stimulated insulin exocytosis.\",\n      \"evidence\": \"RCAN1-overexpressing mice with in vivo insulin secretion, membrane potential, OXPHOS, ATP, and granule exocytosis assays\",\n      \"pmids\": [\"27195491\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Calcineurin-dependence of the β-cell phenotype not isolated\", \"Single-lab transgenic model\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Resolved how RCAN1 maintains mitochondrial fusion by restraining calcineurin-dependent DRP1 activation, and broadened its signaling roles to VEGFR-2 trafficking and LRRK2-Tollip-NF-κB inflammation.\",\n      \"evidence\": \"RCAN1 KO/overexpressing cardiomyocytes with DS iPSC and pharmacological rescue; VEGFR-2 internalization and zebrafish morpholino; LRRK2 kinase, Co-IP, and NF-κB/IL-8 assays\",\n      \"pmids\": [\"29362227\", \"28271280\", \"28553204\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"LRRK2-RCAN1 inflammatory axis (28553204) single-lab and Medium-confidence\", \"Direct DRP1 regulation versus calpain contribution not fully separated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Uncovered a calcineurin-independent epigenetic function whereby RCAN1 binds TET1 introns to regulate splicing and miR-124-dependent adult neurogenesis, and showed DNMT methylation silences RCAN1.4 in fibrosis.\",\n      \"evidence\": \"RCAN1 KO mice with splicing/methylation/neurogenesis assays and TET1 genetic rescue; ChIP/bisulfite analysis with AAV rescue in liver fibrosis\",\n      \"pmids\": [\"31304631\", \"31285763\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Biochemical basis of RCAN1 RNA-binding/splicing activity undefined\", \"Relationship of TET1 role to calcineurin functions unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstrated therapeutic relevance in neurodegeneration, showing RCAN1 knockdown enhances calcineurin-TFEB-autophagy signaling to rescue Huntington's patient-derived neurons, mimicked pharmacologically.\",\n      \"evidence\": \"Patient-derived reprogrammed MSNs with RCAN1 knockdown, calcineurin/TFEB and ATAC-seq readouts, and G2-115 disruption of RCAN1-calcineurin\",\n      \"pmids\": [\"38066314\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo efficacy of RCAN1-calcineurin disruption not established\", \"Specificity of G2-115 for the RCAN1-calcineurin interface not fully characterized\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How RCAN1's calcineurin-dependent and calcineurin-independent activities (RNA/splicing with TET1, FMRP-linked local translation, fusion-pore kinetics) are coordinated, and what structural features encode the inhibitor-versus-facilitator switch, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of the RCAN1-calcineurin complex or of the phosphorylation-dependent conformational switch\", \"Molecular basis of RCAN1 nucleic-acid binding undefined\", \"Quantitative rules governing dosage-dependent role reversal in vivo unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 2, 4, 27]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [21]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [29]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [18, 16, 32]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 3, 7]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 7, 40]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [35, 7]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [27, 26, 25, 9]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [18, 16]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [9, 38]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [31, 6, 34]}\n    ],\n    \"complexes\": [\n      \"TAK1-TAB1-TAB2-calcineurin signaling complex\"\n    ],\n    \"partners\": [\n      \"PPP3CA\",\n      \"DYRK1A\",\n      \"TAB2\",\n      \"TAK1\",\n      \"FMRP\",\n      \"TET1\",\n      \"RAF1\",\n      \"BTRC\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}